CN107156829A - 一种适用于肝病患者的全营养配方食品 - Google Patents
一种适用于肝病患者的全营养配方食品 Download PDFInfo
- Publication number
- CN107156829A CN107156829A CN201710034125.XA CN201710034125A CN107156829A CN 107156829 A CN107156829 A CN 107156829A CN 201710034125 A CN201710034125 A CN 201710034125A CN 107156829 A CN107156829 A CN 107156829A
- Authority
- CN
- China
- Prior art keywords
- leaf
- flower
- selenium
- effect
- blood
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013305 food Nutrition 0.000 title claims abstract description 47
- 235000016709 nutrition Nutrition 0.000 title claims abstract description 25
- 230000035764 nutrition Effects 0.000 title claims abstract description 23
- 239000011669 selenium Substances 0.000 claims abstract description 69
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims abstract description 61
- 229910052711 selenium Inorganic materials 0.000 claims abstract description 61
- 210000000582 semen Anatomy 0.000 claims abstract description 35
- 241000196324 Embryophyta Species 0.000 claims abstract description 33
- 239000000843 powder Substances 0.000 claims abstract description 28
- 239000000203 mixture Substances 0.000 claims abstract description 24
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims abstract description 22
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 21
- 244000068988 Glycine max Species 0.000 claims abstract description 21
- 235000010355 mannitol Nutrition 0.000 claims abstract description 10
- 235000013399 edible fruits Nutrition 0.000 claims description 54
- 235000018958 Gardenia augusta Nutrition 0.000 claims description 45
- 235000002555 Citrus medica var sarcodactylis Nutrition 0.000 claims description 34
- 241000628997 Flos Species 0.000 claims description 32
- 244000111489 Gardenia augusta Species 0.000 claims description 31
- 240000008397 Ganoderma lucidum Species 0.000 claims description 30
- 235000001637 Ganoderma lucidum Nutrition 0.000 claims description 29
- 240000004307 Citrus medica Species 0.000 claims description 25
- 235000001938 Citrus medica Nutrition 0.000 claims description 24
- 244000268590 Euryale ferox Species 0.000 claims description 24
- 241000241413 Propolis Species 0.000 claims description 24
- 241000245665 Taraxacum Species 0.000 claims description 24
- 229940069949 propolis Drugs 0.000 claims description 24
- 244000077995 Coix lacryma jobi Species 0.000 claims description 23
- 235000005187 Taraxacum officinale ssp. officinale Nutrition 0.000 claims description 23
- 240000007594 Oryza sativa Species 0.000 claims description 22
- 235000007164 Oryza sativa Nutrition 0.000 claims description 22
- VYQNWZOUAUKGHI-UHFFFAOYSA-N monobenzone Chemical compound C1=CC(O)=CC=C1OCC1=CC=CC=C1 VYQNWZOUAUKGHI-UHFFFAOYSA-N 0.000 claims description 21
- 235000009566 rice Nutrition 0.000 claims description 21
- 235000009917 Crataegus X brevipes Nutrition 0.000 claims description 20
- 235000013204 Crataegus X haemacarpa Nutrition 0.000 claims description 20
- 235000009685 Crataegus X maligna Nutrition 0.000 claims description 20
- 235000009444 Crataegus X rubrocarnea Nutrition 0.000 claims description 20
- 235000009486 Crataegus bullatus Nutrition 0.000 claims description 20
- 235000017181 Crataegus chrysocarpa Nutrition 0.000 claims description 20
- 235000009682 Crataegus limnophila Nutrition 0.000 claims description 20
- 240000000171 Crataegus monogyna Species 0.000 claims description 20
- 235000004423 Crataegus monogyna Nutrition 0.000 claims description 20
- 235000002313 Crataegus paludosa Nutrition 0.000 claims description 20
- 235000009840 Crataegus x incaedua Nutrition 0.000 claims description 20
- 235000006487 Euryale ferox Nutrition 0.000 claims description 20
- 240000004638 Dendrobium nobile Species 0.000 claims description 19
- 240000002853 Nelumbo nucifera Species 0.000 claims description 17
- 235000006508 Nelumbo nucifera Nutrition 0.000 claims description 17
- 235000006510 Nelumbo pentapetala Nutrition 0.000 claims description 17
- 241000124033 Salix Species 0.000 claims description 17
- 244000037364 Cinnamomum aromaticum Species 0.000 claims description 16
- 235000014489 Cinnamomum aromaticum Nutrition 0.000 claims description 16
- 241001264174 Cordyceps militaris Species 0.000 claims description 16
- 244000179886 Moringa oleifera Species 0.000 claims description 16
- 235000011347 Moringa oleifera Nutrition 0.000 claims description 16
- 235000011158 Prunus mume Nutrition 0.000 claims description 16
- 244000018795 Prunus mume Species 0.000 claims description 16
- 244000234609 Portulaca oleracea Species 0.000 claims description 15
- 235000001855 Portulaca oleracea Nutrition 0.000 claims description 15
- 241000195620 Euglena Species 0.000 claims description 14
- 244000246386 Mentha pulegium Species 0.000 claims description 14
- 235000016257 Mentha pulegium Nutrition 0.000 claims description 14
- 235000004357 Mentha x piperita Nutrition 0.000 claims description 14
- 235000001050 hortel pimenta Nutrition 0.000 claims description 14
- 241000208688 Eucommia Species 0.000 claims description 13
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 claims description 13
- 235000009388 Parthenocissus quinquefolia Nutrition 0.000 claims description 13
- 244000046052 Phaseolus vulgaris Species 0.000 claims description 13
- 235000009467 Carica papaya Nutrition 0.000 claims description 12
- 241000207199 Citrus Species 0.000 claims description 12
- 235000006484 Paeonia officinalis Nutrition 0.000 claims description 12
- 235000020971 citrus fruits Nutrition 0.000 claims description 12
- 240000007126 Citrus medica var. sarcodactylis Species 0.000 claims description 11
- 241000233805 Phoenix Species 0.000 claims description 11
- 235000005489 dwarf bean Nutrition 0.000 claims description 11
- 235000006264 Asimina triloba Nutrition 0.000 claims description 10
- 244000007853 Sarothamnus scoparius Species 0.000 claims description 10
- 235000003434 Sesamum indicum Nutrition 0.000 claims description 5
- 244000170916 Paeonia officinalis Species 0.000 claims description 4
- 239000008188 pellet Substances 0.000 claims description 3
- 235000008331 Pinus X rigitaeda Nutrition 0.000 claims description 2
- 235000011613 Pinus brutia Nutrition 0.000 claims description 2
- 241000018646 Pinus brutia Species 0.000 claims description 2
- 244000189799 Asimina triloba Species 0.000 claims 3
- 241000219099 Parthenocissus quinquefolia Species 0.000 claims 3
- 244000000231 Sesamum indicum Species 0.000 claims 1
- 240000001949 Taraxacum officinale Species 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 94
- 210000004185 liver Anatomy 0.000 abstract description 43
- 230000006870 function Effects 0.000 abstract description 34
- 230000007774 longterm Effects 0.000 abstract description 7
- 241000411851 herbal medicine Species 0.000 abstract description 6
- 235000015097 nutrients Nutrition 0.000 abstract description 6
- 230000031891 intestinal absorption Effects 0.000 abstract description 3
- 238000007796 conventional method Methods 0.000 abstract description 2
- 235000011649 selenium Nutrition 0.000 description 55
- 210000004369 blood Anatomy 0.000 description 42
- 239000008280 blood Substances 0.000 description 42
- 239000003814 drug Substances 0.000 description 42
- 210000002784 stomach Anatomy 0.000 description 32
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 28
- 201000010099 disease Diseases 0.000 description 27
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 24
- 210000000952 spleen Anatomy 0.000 description 24
- 239000000284 extract Substances 0.000 description 22
- 235000019197 fats Nutrition 0.000 description 21
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 21
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 20
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 19
- 235000019441 ethanol Nutrition 0.000 description 19
- 239000000047 product Substances 0.000 description 19
- 210000003734 kidney Anatomy 0.000 description 18
- 210000004027 cell Anatomy 0.000 description 15
- 235000009508 confectionery Nutrition 0.000 description 15
- 238000011160 research Methods 0.000 description 15
- 240000001972 Gardenia jasminoides Species 0.000 description 14
- 241000699666 Mus <mouse, genus> Species 0.000 description 14
- 241000700159 Rattus Species 0.000 description 14
- 230000002829 reductive effect Effects 0.000 description 13
- 230000001989 choleretic effect Effects 0.000 description 12
- 230000002401 inhibitory effect Effects 0.000 description 12
- 229910052742 iron Inorganic materials 0.000 description 12
- 229960003284 iron Drugs 0.000 description 12
- 230000004224 protection Effects 0.000 description 12
- 241000563984 Ampelopsis Species 0.000 description 11
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 11
- 241000283973 Oryctolagus cuniculus Species 0.000 description 11
- 230000009471 action Effects 0.000 description 11
- 150000004676 glycans Chemical class 0.000 description 11
- 229920001282 polysaccharide Polymers 0.000 description 11
- 239000005017 polysaccharide Substances 0.000 description 11
- 230000001737 promoting effect Effects 0.000 description 11
- 235000014101 wine Nutrition 0.000 description 11
- 240000006432 Carica papaya Species 0.000 description 10
- 240000005250 Chrysanthemum indicum Species 0.000 description 10
- 235000007354 Coix lacryma jobi Nutrition 0.000 description 10
- 241001122767 Theaceae Species 0.000 description 10
- 230000015572 biosynthetic process Effects 0.000 description 10
- 235000012000 cholesterol Nutrition 0.000 description 10
- 230000007812 deficiency Effects 0.000 description 10
- 229930003944 flavone Natural products 0.000 description 10
- 235000011949 flavones Nutrition 0.000 description 10
- 210000002216 heart Anatomy 0.000 description 10
- 239000002398 materia medica Substances 0.000 description 10
- -1 methyl enol Chemical class 0.000 description 10
- 231100000614 poison Toxicity 0.000 description 10
- 230000002265 prevention Effects 0.000 description 10
- VZGDMQKNWNREIO-UHFFFAOYSA-N tetrachloromethane Chemical compound ClC(Cl)(Cl)Cl VZGDMQKNWNREIO-UHFFFAOYSA-N 0.000 description 10
- 230000035922 thirst Effects 0.000 description 10
- 206010011224 Cough Diseases 0.000 description 9
- IBFYXTRXDNAPMM-BVTMAQQCSA-N Geniposide Chemical compound O([C@@H]1OC=C([C@@H]2[C@H]1C(=CC2)CO)C(=O)OC)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O IBFYXTRXDNAPMM-BVTMAQQCSA-N 0.000 description 9
- IBFYXTRXDNAPMM-FZEIBHLUSA-N Geniposide Natural products COC(=O)C1=CO[C@@H](O[C@H]2O[C@@H](CO)[C@H](O)[C@@H](O)[C@@H]2O)[C@H]2[C@@H]1CC=C2CO IBFYXTRXDNAPMM-FZEIBHLUSA-N 0.000 description 9
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 9
- 230000003712 anti-aging effect Effects 0.000 description 9
- 230000036528 appetite Effects 0.000 description 9
- 235000019789 appetite Nutrition 0.000 description 9
- VGLLGNISLBPZNL-RBUKDIBWSA-N arborescoside Natural products O=C(OC)C=1[C@@H]2C([C@H](O[C@H]3[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O3)OC=1)=C(CO)CC2 VGLLGNISLBPZNL-RBUKDIBWSA-N 0.000 description 9
- 239000007789 gas Substances 0.000 description 9
- 230000001077 hypotensive effect Effects 0.000 description 9
- 230000036039 immunity Effects 0.000 description 9
- 210000004072 lung Anatomy 0.000 description 9
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 8
- 235000007516 Chrysanthemum Nutrition 0.000 description 8
- 206010012735 Diarrhoea Diseases 0.000 description 8
- 206010062717 Increased upper airway secretion Diseases 0.000 description 8
- 206010028980 Neoplasm Diseases 0.000 description 8
- 241001248610 Ophiocordyceps sinensis Species 0.000 description 8
- 241000736199 Paeonia Species 0.000 description 8
- 239000002253 acid Substances 0.000 description 8
- 230000003110 anti-inflammatory effect Effects 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 8
- 210000004204 blood vessel Anatomy 0.000 description 8
- 208000002173 dizziness Diseases 0.000 description 8
- 229940079593 drug Drugs 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000036541 health Effects 0.000 description 8
- 210000000936 intestine Anatomy 0.000 description 8
- 230000000144 pharmacologic effect Effects 0.000 description 8
- 208000026435 phlegm Diseases 0.000 description 8
- 239000002574 poison Substances 0.000 description 8
- 230000001681 protective effect Effects 0.000 description 8
- NOOLISFMXDJSKH-KXUCPTDWSA-N (-)-Menthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1O NOOLISFMXDJSKH-KXUCPTDWSA-N 0.000 description 7
- 208000002193 Pain Diseases 0.000 description 7
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 description 7
- 230000000844 anti-bacterial effect Effects 0.000 description 7
- 230000003078 antioxidant effect Effects 0.000 description 7
- 210000000941 bile Anatomy 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 7
- 230000029087 digestion Effects 0.000 description 7
- 230000002708 enhancing effect Effects 0.000 description 7
- 230000001976 improved effect Effects 0.000 description 7
- 239000000463 material Substances 0.000 description 7
- 238000010791 quenching Methods 0.000 description 7
- 230000001603 reducing effect Effects 0.000 description 7
- 235000014347 soups Nutrition 0.000 description 7
- 208000024891 symptom Diseases 0.000 description 7
- 235000015961 tonic Nutrition 0.000 description 7
- 230000001256 tonic effect Effects 0.000 description 7
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 description 7
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 6
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 206010010904 Convulsion Diseases 0.000 description 6
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 6
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 6
- 244000046146 Pueraria lobata Species 0.000 description 6
- 235000010575 Pueraria lobata Nutrition 0.000 description 6
- 240000006365 Vitis vinifera Species 0.000 description 6
- 235000014787 Vitis vinifera Nutrition 0.000 description 6
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 6
- 239000003963 antioxidant agent Substances 0.000 description 6
- 235000006708 antioxidants Nutrition 0.000 description 6
- 208000006673 asthma Diseases 0.000 description 6
- 230000008901 benefit Effects 0.000 description 6
- 201000011510 cancer Diseases 0.000 description 6
- 230000002354 daily effect Effects 0.000 description 6
- 235000012907 honey Nutrition 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- 235000010445 lecithin Nutrition 0.000 description 6
- 239000000787 lecithin Substances 0.000 description 6
- 229940067606 lecithin Drugs 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229940041616 menthol Drugs 0.000 description 6
- 230000036407 pain Effects 0.000 description 6
- 230000028327 secretion Effects 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 230000001225 therapeutic effect Effects 0.000 description 6
- 239000011573 trace mineral Substances 0.000 description 6
- 235000013619 trace mineral Nutrition 0.000 description 6
- 210000002700 urine Anatomy 0.000 description 6
- 229910052725 zinc Inorganic materials 0.000 description 6
- 239000011701 zinc Substances 0.000 description 6
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 5
- 244000025254 Cannabis sativa Species 0.000 description 5
- 206010010774 Constipation Diseases 0.000 description 5
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 5
- 102000004190 Enzymes Human genes 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 5
- QUQPHWDTPGMPEX-UHFFFAOYSA-N Hesperidine Natural products C1=C(O)C(OC)=CC=C1C1OC2=CC(OC3C(C(O)C(O)C(COC4C(C(O)C(O)C(C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-UHFFFAOYSA-N 0.000 description 5
- 206010020772 Hypertension Diseases 0.000 description 5
- 208000004880 Polyuria Diseases 0.000 description 5
- 229930003268 Vitamin C Natural products 0.000 description 5
- 206010003549 asthenia Diseases 0.000 description 5
- 229910052791 calcium Inorganic materials 0.000 description 5
- 239000011575 calcium Substances 0.000 description 5
- 235000001465 calcium Nutrition 0.000 description 5
- 230000035603 choleresis Effects 0.000 description 5
- 230000004087 circulation Effects 0.000 description 5
- 230000036461 convulsion Effects 0.000 description 5
- 208000029078 coronary artery disease Diseases 0.000 description 5
- 230000035619 diuresis Effects 0.000 description 5
- 201000006549 dyspepsia Diseases 0.000 description 5
- 229940088598 enzyme Drugs 0.000 description 5
- 206010016256 fatigue Diseases 0.000 description 5
- 239000003205 fragrance Substances 0.000 description 5
- 210000000232 gallbladder Anatomy 0.000 description 5
- 208000006454 hepatitis Diseases 0.000 description 5
- QUQPHWDTPGMPEX-QJBIFVCTSA-N hesperidin Chemical compound C1=C(O)C(OC)=CC=C1[C@H]1OC2=CC(O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]4[C@@H]([C@H](O)[C@@H](O)[C@H](C)O4)O)O3)O)=CC(O)=C2C(=O)C1 QUQPHWDTPGMPEX-QJBIFVCTSA-N 0.000 description 5
- 238000000338 in vitro Methods 0.000 description 5
- 238000001990 intravenous administration Methods 0.000 description 5
- 230000001717 pathogenic effect Effects 0.000 description 5
- 235000018102 proteins Nutrition 0.000 description 5
- 102000004169 proteins and genes Human genes 0.000 description 5
- 108090000623 proteins and genes Proteins 0.000 description 5
- 230000009467 reduction Effects 0.000 description 5
- 230000035900 sweating Effects 0.000 description 5
- 229930003231 vitamin Natural products 0.000 description 5
- 235000013343 vitamin Nutrition 0.000 description 5
- 239000011782 vitamin Substances 0.000 description 5
- 229940088594 vitamin Drugs 0.000 description 5
- 235000019154 vitamin C Nutrition 0.000 description 5
- 239000011718 vitamin C Substances 0.000 description 5
- KJXSIXMJHKAJOD-LSDHHAIUSA-N (+)-dihydromyricetin Chemical compound C1([C@@H]2[C@H](C(C3=C(O)C=C(O)C=C3O2)=O)O)=CC(O)=C(O)C(O)=C1 KJXSIXMJHKAJOD-LSDHHAIUSA-N 0.000 description 4
- NXJCRELRQHZBQA-UHFFFAOYSA-N 5,7-dimethoxy-1-benzopyran-2-one Chemical compound C1=CC(=O)OC2=CC(OC)=CC(OC)=C21 NXJCRELRQHZBQA-UHFFFAOYSA-N 0.000 description 4
- 206010000087 Abdominal pain upper Diseases 0.000 description 4
- 208000007848 Alcoholism Diseases 0.000 description 4
- BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- 241000675108 Citrus tangerina Species 0.000 description 4
- 102000002322 Egg Proteins Human genes 0.000 description 4
- 108010000912 Egg Proteins Proteins 0.000 description 4
- NTYJJOPFIAHURM-UHFFFAOYSA-N Histamine Chemical compound NCCC1=CN=CN1 NTYJJOPFIAHURM-UHFFFAOYSA-N 0.000 description 4
- 208000001953 Hypotension Diseases 0.000 description 4
- 206010023126 Jaundice Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 4
- 244000040738 Sesamum orientale Species 0.000 description 4
- 208000007107 Stomach Ulcer Diseases 0.000 description 4
- 229930003427 Vitamin E Natural products 0.000 description 4
- 206010047700 Vomiting Diseases 0.000 description 4
- UCTWMZQNUQWSLP-UHFFFAOYSA-N adrenaline Chemical compound CNCC(O)C1=CC=C(O)C(O)=C1 UCTWMZQNUQWSLP-UHFFFAOYSA-N 0.000 description 4
- 201000007930 alcohol dependence Diseases 0.000 description 4
- 230000000840 anti-viral effect Effects 0.000 description 4
- 210000001367 artery Anatomy 0.000 description 4
- 230000036772 blood pressure Effects 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 230000008859 change Effects 0.000 description 4
- 210000000038 chest Anatomy 0.000 description 4
- LQGUBLBATBMXHT-UHFFFAOYSA-N chrysophanol Chemical compound C1=CC=C2C(=O)C3=CC(C)=CC(O)=C3C(=O)C2=C1O LQGUBLBATBMXHT-UHFFFAOYSA-N 0.000 description 4
- 230000008602 contraction Effects 0.000 description 4
- 230000007423 decrease Effects 0.000 description 4
- 230000002996 emotional effect Effects 0.000 description 4
- 210000003414 extremity Anatomy 0.000 description 4
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 4
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 4
- 230000002496 gastric effect Effects 0.000 description 4
- 201000005917 gastric ulcer Diseases 0.000 description 4
- 230000012010 growth Effects 0.000 description 4
- 208000021822 hypotensive Diseases 0.000 description 4
- 230000036737 immune function Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000000968 intestinal effect Effects 0.000 description 4
- 239000007928 intraperitoneal injection Substances 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 210000005229 liver cell Anatomy 0.000 description 4
- 208000019423 liver disease Diseases 0.000 description 4
- 230000003908 liver function Effects 0.000 description 4
- 230000033001 locomotion Effects 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 230000004060 metabolic process Effects 0.000 description 4
- 150000007524 organic acids Chemical class 0.000 description 4
- 150000003254 radicals Chemical class 0.000 description 4
- 201000010153 skin papilloma Diseases 0.000 description 4
- 230000007958 sleep Effects 0.000 description 4
- 239000002689 soil Substances 0.000 description 4
- 238000005728 strengthening Methods 0.000 description 4
- 230000001502 supplementing effect Effects 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 210000003462 vein Anatomy 0.000 description 4
- 235000019165 vitamin E Nutrition 0.000 description 4
- 229940046009 vitamin E Drugs 0.000 description 4
- 239000011709 vitamin E Substances 0.000 description 4
- 230000008673 vomiting Effects 0.000 description 4
- 239000002023 wood Substances 0.000 description 4
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 206010002383 Angina Pectoris Diseases 0.000 description 3
- 241000193830 Bacillus <bacterium> Species 0.000 description 3
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 3
- PANKHBYNKQNAHN-JTBLXSOISA-N Crocetin Natural products OC(=O)C(\C)=C/C=C/C(/C)=C\C=C\C=C(\C)/C=C/C=C(/C)C(O)=O PANKHBYNKQNAHN-JTBLXSOISA-N 0.000 description 3
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 3
- SEBIKDIMAPSUBY-JAUCNNNOSA-N Crocin Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)OC1OC(COC2OC(CO)C(O)C(O)C2O)C(O)C(O)C1O)C=CC=C(/C)C(=O)OC3OC(COC4OC(CO)C(O)C(O)C4O)C(O)C(O)C3O SEBIKDIMAPSUBY-JAUCNNNOSA-N 0.000 description 3
- 241000026010 Dendrobium candidum Species 0.000 description 3
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 3
- 241000282326 Felis catus Species 0.000 description 3
- 241000222336 Ganoderma Species 0.000 description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 3
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- 241000255640 Loa loa Species 0.000 description 3
- 241000218378 Magnolia Species 0.000 description 3
- 241000699670 Mus sp. Species 0.000 description 3
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 3
- 206010028851 Necrosis Diseases 0.000 description 3
- 240000004371 Panax ginseng Species 0.000 description 3
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 3
- 235000003140 Panax quinquefolius Nutrition 0.000 description 3
- CWRVKFFCRWGWCS-UHFFFAOYSA-N Pentrazole Chemical compound C1CCCCC2=NN=NN21 CWRVKFFCRWGWCS-UHFFFAOYSA-N 0.000 description 3
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 3
- 206010039921 Selenium deficiency Diseases 0.000 description 3
- 241000191967 Staphylococcus aureus Species 0.000 description 3
- 241000270666 Testudines Species 0.000 description 3
- 208000007536 Thrombosis Diseases 0.000 description 3
- 208000025865 Ulcer Diseases 0.000 description 3
- 208000000260 Warts Diseases 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 125000001931 aliphatic group Chemical group 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 230000000202 analgesic effect Effects 0.000 description 3
- 229930014669 anthocyanidin Natural products 0.000 description 3
- 150000001452 anthocyanidin derivatives Chemical class 0.000 description 3
- 235000008758 anthocyanidins Nutrition 0.000 description 3
- 230000002158 anti-implantation Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 210000001124 body fluid Anatomy 0.000 description 3
- 239000010839 body fluid Substances 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 150000001720 carbohydrates Chemical class 0.000 description 3
- 235000014633 carbohydrates Nutrition 0.000 description 3
- 210000000748 cardiovascular system Anatomy 0.000 description 3
- PANKHBYNKQNAHN-JUMCEFIXSA-N carotenoid dicarboxylic acid Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C(=O)O)C=CC=C(/C)C(=O)O PANKHBYNKQNAHN-JUMCEFIXSA-N 0.000 description 3
- 238000006243 chemical reaction Methods 0.000 description 3
- 230000002279 cholagogic effect Effects 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- PANKHBYNKQNAHN-MQQNZMFNSA-N crocetin Chemical compound OC(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C(O)=O PANKHBYNKQNAHN-MQQNZMFNSA-N 0.000 description 3
- 239000013078 crystal Substances 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 230000006837 decompression Effects 0.000 description 3
- 230000002526 effect on cardiovascular system Effects 0.000 description 3
- 235000014103 egg white Nutrition 0.000 description 3
- 210000000969 egg white Anatomy 0.000 description 3
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 3
- 150000002213 flavones Chemical class 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000014106 fortified food Nutrition 0.000 description 3
- 208000001130 gallstones Diseases 0.000 description 3
- 235000008434 ginseng Nutrition 0.000 description 3
- 210000004907 gland Anatomy 0.000 description 3
- 239000008103 glucose Substances 0.000 description 3
- 229930182478 glucoside Natural products 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 230000002440 hepatic effect Effects 0.000 description 3
- 231100000753 hepatic injury Toxicity 0.000 description 3
- 231100000283 hepatitis Toxicity 0.000 description 3
- 238000001727 in vivo Methods 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000007924 injection Substances 0.000 description 3
- 238000002347 injection Methods 0.000 description 3
- 208000014674 injury Diseases 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- 210000002429 large intestine Anatomy 0.000 description 3
- 235000012054 meals Nutrition 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 230000007246 mechanism Effects 0.000 description 3
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 3
- HVHKMUMXERBUAN-IFADSCNNSA-N mesobilirubin IXalpha Chemical compound N1C(=O)C(CC)=C(C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C)C(=O)N\3)CC)N2)CCC(O)=O)N1 HVHKMUMXERBUAN-IFADSCNNSA-N 0.000 description 3
- 230000004089 microcirculation Effects 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 230000003020 moisturizing effect Effects 0.000 description 3
- 230000009854 mucosal lesion Effects 0.000 description 3
- 208000031225 myocardial ischemia Diseases 0.000 description 3
- 230000017074 necrotic cell death Effects 0.000 description 3
- 230000000422 nocturnal effect Effects 0.000 description 3
- 235000008935 nutritious Nutrition 0.000 description 3
- 210000000496 pancreas Anatomy 0.000 description 3
- 235000019477 peppermint oil Nutrition 0.000 description 3
- 239000011591 potassium Substances 0.000 description 3
- 229910052700 potassium Inorganic materials 0.000 description 3
- 238000002360 preparation method Methods 0.000 description 3
- 238000012545 processing Methods 0.000 description 3
- 208000008128 pulmonary tuberculosis Diseases 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 3
- 230000008929 regeneration Effects 0.000 description 3
- 238000011069 regeneration method Methods 0.000 description 3
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 3
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 3
- 235000005493 rutin Nutrition 0.000 description 3
- 229960004555 rutoside Drugs 0.000 description 3
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 3
- 229960002646 scopolamine Drugs 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000011734 sodium Substances 0.000 description 3
- 229910052708 sodium Inorganic materials 0.000 description 3
- 230000008925 spontaneous activity Effects 0.000 description 3
- 208000010110 spontaneous platelet aggregation Diseases 0.000 description 3
- 230000001629 suppression Effects 0.000 description 3
- 208000011580 syndromic disease Diseases 0.000 description 3
- 231100000397 ulcer Toxicity 0.000 description 3
- 229940096998 ursolic acid Drugs 0.000 description 3
- PLSAJKYPRJGMHO-UHFFFAOYSA-N ursolic acid Natural products CC1CCC2(CCC3(C)C(C=CC4C5(C)CCC(O)C(C)(C)C5CCC34C)C2C1C)C(=O)O PLSAJKYPRJGMHO-UHFFFAOYSA-N 0.000 description 3
- 235000013311 vegetables Nutrition 0.000 description 3
- 150000003722 vitamin derivatives Chemical class 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- QCHFTSOMWOSFHM-WPRPVWTQSA-N (+)-Pilocarpine Chemical compound C1OC(=O)[C@@H](CC)[C@H]1CC1=CN=CN1C QCHFTSOMWOSFHM-WPRPVWTQSA-N 0.000 description 2
- HSINOMROUCMIEA-FGVHQWLLSA-N (2s,4r)-4-[(3r,5s,6r,7r,8s,9s,10s,13r,14s,17r)-6-ethyl-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1h-cyclopenta[a]phenanthren-17-yl]-2-methylpentanoic acid Chemical compound C([C@@]12C)C[C@@H](O)C[C@H]1[C@@H](CC)[C@@H](O)[C@@H]1[C@@H]2CC[C@]2(C)[C@@H]([C@H](C)C[C@H](C)C(O)=O)CC[C@H]21 HSINOMROUCMIEA-FGVHQWLLSA-N 0.000 description 2
- WCGUUGGRBIKTOS-GPOJBZKASA-N (3beta)-3-hydroxyurs-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CC[C@@H](C)[C@H](C)[C@H]5C4=CC[C@@H]3[C@]21C WCGUUGGRBIKTOS-GPOJBZKASA-N 0.000 description 2
- BAHMQESJBKGPTE-UHFFFAOYSA-N 1,5,8-trimethyl-3a,4-dihydroazuleno[6,5-b]furan-2,6-dione Chemical compound C1C2OC(=O)C(C)=C2C=C2C(C)=CC(=O)C2=C1C BAHMQESJBKGPTE-UHFFFAOYSA-N 0.000 description 2
- GZSOSUNBTXMUFQ-NJGQXECBSA-N 5,7,3'-Trihydroxy-4'-methoxyflavone 7-O-rutinoside Natural products O(C[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@H](Oc2cc(O)c3C(=O)C=C(c4cc(O)c(OC)cc4)Oc3c2)O1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](C)O1 GZSOSUNBTXMUFQ-NJGQXECBSA-N 0.000 description 2
- BGEBZHIAGXMEMV-UHFFFAOYSA-N 5-methoxypsoralen Chemical compound O1C(=O)C=CC2=C1C=C1OC=CC1=C2OC BGEBZHIAGXMEMV-UHFFFAOYSA-N 0.000 description 2
- YDQWDHRMZQUTBA-UHFFFAOYSA-N Aloe emodin Chemical compound C1=CC=C2C(=O)C3=CC(CO)=CC(O)=C3C(=O)C2=C1O YDQWDHRMZQUTBA-UHFFFAOYSA-N 0.000 description 2
- 241001480043 Arthrodermataceae Species 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 208000037260 Atherosclerotic Plaque Diseases 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- 208000004429 Bacillary Dysentery Diseases 0.000 description 2
- 241000894006 Bacteria Species 0.000 description 2
- 206010006187 Breast cancer Diseases 0.000 description 2
- 208000026310 Breast neoplasm Diseases 0.000 description 2
- 102100034279 Calcium-binding mitochondrial carrier protein Aralar2 Human genes 0.000 description 2
- 201000009030 Carcinoma Diseases 0.000 description 2
- 208000024172 Cardiovascular disease Diseases 0.000 description 2
- 241000700199 Cavia porcellus Species 0.000 description 2
- VYZAMTAEIAYCRO-UHFFFAOYSA-N Chromium Chemical compound [Cr] VYZAMTAEIAYCRO-UHFFFAOYSA-N 0.000 description 2
- 206010008909 Chronic Hepatitis Diseases 0.000 description 2
- 235000018959 Chrysanthemum indicum Nutrition 0.000 description 2
- 244000183685 Citrus aurantium Species 0.000 description 2
- 235000007716 Citrus aurantium Nutrition 0.000 description 2
- 241000233779 Cyclocarya paliurus Species 0.000 description 2
- 241000721047 Danaus plexippus Species 0.000 description 2
- 208000008967 Enuresis Diseases 0.000 description 2
- 208000004930 Fatty Liver Diseases 0.000 description 2
- 241001480597 Ganoderma tsugae Species 0.000 description 2
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 2
- GLZPCOQZEFWAFX-UHFFFAOYSA-N Geraniol Chemical compound CC(C)=CCCC(C)=CCO GLZPCOQZEFWAFX-UHFFFAOYSA-N 0.000 description 2
- 206010018612 Gonorrhoea Diseases 0.000 description 2
- 206010019233 Headaches Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 208000000616 Hemoptysis Diseases 0.000 description 2
- 206010019708 Hepatic steatosis Diseases 0.000 description 2
- 244000153234 Hibiscus abelmoschus Species 0.000 description 2
- 208000031226 Hyperlipidaemia Diseases 0.000 description 2
- 235000002710 Ilex cornuta Nutrition 0.000 description 2
- 108060003951 Immunoglobulin Proteins 0.000 description 2
- 201000001429 Intracranial Thrombosis Diseases 0.000 description 2
- 102000011782 Keratins Human genes 0.000 description 2
- 108010076876 Keratins Proteins 0.000 description 2
- 241000589902 Leptospira Species 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- XUMBMVFBXHLACL-UHFFFAOYSA-N Melanin Chemical compound O=C1C(=O)C(C2=CNC3=C(C(C(=O)C4=C32)=O)C)=C2C4=CNC2=C1C XUMBMVFBXHLACL-UHFFFAOYSA-N 0.000 description 2
- 235000014435 Mentha Nutrition 0.000 description 2
- 241001072983 Mentha Species 0.000 description 2
- 235000014749 Mentha crispa Nutrition 0.000 description 2
- 241000192041 Micrococcus Species 0.000 description 2
- 244000179970 Monarda didyma Species 0.000 description 2
- 235000010672 Monarda didyma Nutrition 0.000 description 2
- 208000007443 Neurasthenia Diseases 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 206010030113 Oedema Diseases 0.000 description 2
- 241000588278 Osmanthus heterophyllus Species 0.000 description 2
- 235000010326 Osmanthus heterophyllus Nutrition 0.000 description 2
- 206010033645 Pancreatitis Diseases 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- 208000005374 Poisoning Diseases 0.000 description 2
- 206010036790 Productive cough Diseases 0.000 description 2
- 241000588769 Proteus <enterobacteria> Species 0.000 description 2
- 241000589517 Pseudomonas aeruginosa Species 0.000 description 2
- 206010037660 Pyrexia Diseases 0.000 description 2
- REFJWTPEDVJJIY-UHFFFAOYSA-N Quercetin Chemical compound C=1C(O)=CC(O)=C(C(C=2O)=O)C=1OC=2C1=CC=C(O)C(O)=C1 REFJWTPEDVJJIY-UHFFFAOYSA-N 0.000 description 2
- 241001093501 Rutaceae Species 0.000 description 2
- 208000034189 Sclerosis Diseases 0.000 description 2
- 206010039897 Sedation Diseases 0.000 description 2
- 241000607764 Shigella dysenteriae Species 0.000 description 2
- 241000194017 Streptococcus Species 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- OUUQCZGPVNCOIJ-UHFFFAOYSA-M Superoxide Chemical class [O-][O] OUUQCZGPVNCOIJ-UHFFFAOYSA-M 0.000 description 2
- GUGOEEXESWIERI-UHFFFAOYSA-N Terfenadine Chemical compound C1=CC(C(C)(C)C)=CC=C1C(O)CCCN1CCC(C(O)(C=2C=CC=CC=2)C=2C=CC=CC=2)CC1 GUGOEEXESWIERI-UHFFFAOYSA-N 0.000 description 2
- 206010044302 Tracheitis Diseases 0.000 description 2
- 235000021307 Triticum Nutrition 0.000 description 2
- 244000098338 Triticum aestivum Species 0.000 description 2
- 241000256856 Vespidae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 210000001015 abdomen Anatomy 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 239000004480 active ingredient Substances 0.000 description 2
- OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 description 2
- 239000012675 alcoholic extract Substances 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000000954 anitussive effect Effects 0.000 description 2
- 230000001093 anti-cancer Effects 0.000 description 2
- 230000003466 anti-cipated effect Effects 0.000 description 2
- 230000001387 anti-histamine Effects 0.000 description 2
- 230000003276 anti-hypertensive effect Effects 0.000 description 2
- 230000000118 anti-neoplastic effect Effects 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 230000000259 anti-tumor effect Effects 0.000 description 2
- 230000000767 anti-ulcer Effects 0.000 description 2
- 230000002155 anti-virotic effect Effects 0.000 description 2
- 239000000739 antihistaminic agent Substances 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 239000006286 aqueous extract Substances 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 208000010668 atopic eczema Diseases 0.000 description 2
- 230000003190 augmentative effect Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 239000003613 bile acid Substances 0.000 description 2
- 230000033228 biological regulation Effects 0.000 description 2
- 230000000157 blood function Effects 0.000 description 2
- 210000001772 blood platelet Anatomy 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 2
- 230000000747 cardiac effect Effects 0.000 description 2
- 239000002368 cardiac glycoside Substances 0.000 description 2
- 229940097217 cardiac glycoside Drugs 0.000 description 2
- 239000000496 cardiotonic agent Substances 0.000 description 2
- 235000013339 cereals Nutrition 0.000 description 2
- 208000026106 cerebrovascular disease Diseases 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 229910052804 chromium Inorganic materials 0.000 description 2
- 239000011651 chromium Substances 0.000 description 2
- 208000019902 chronic diarrheal disease Diseases 0.000 description 2
- NZPQWZZXRKZCDU-UHFFFAOYSA-N chrysophanol Natural products Cc1cc(O)c2C(=O)c3c(O)cccc3Oc2c1 NZPQWZZXRKZCDU-UHFFFAOYSA-N 0.000 description 2
- 108010084210 citrin Proteins 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- 238000004140 cleaning Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000034994 death Effects 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 230000006735 deficit Effects 0.000 description 2
- 230000003111 delayed effect Effects 0.000 description 2
- 230000037304 dermatophytes Effects 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 210000002249 digestive system Anatomy 0.000 description 2
- KQILIWXGGKGKNX-UHFFFAOYSA-N dihydromyricetin Natural products OC1C(=C(Oc2cc(O)cc(O)c12)c3cc(O)c(O)c(O)c3)O KQILIWXGGKGKNX-UHFFFAOYSA-N 0.000 description 2
- GZSOSUNBTXMUFQ-YFAPSIMESA-N diosmin Chemical compound C1=C(O)C(OC)=CC=C1C(OC1=C2)=CC(=O)C1=C(O)C=C2O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)O1 GZSOSUNBTXMUFQ-YFAPSIMESA-N 0.000 description 2
- 229960004352 diosmin Drugs 0.000 description 2
- IGBKNLGEMMEWKD-UHFFFAOYSA-N diosmin Natural products COc1ccc(cc1)C2=C(O)C(=O)c3c(O)cc(OC4OC(COC5OC(C)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 IGBKNLGEMMEWKD-UHFFFAOYSA-N 0.000 description 2
- 208000017574 dry cough Diseases 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 208000001848 dysentery Diseases 0.000 description 2
- 230000008030 elimination Effects 0.000 description 2
- 238000003379 elimination reaction Methods 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 230000029142 excretion Effects 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 208000010706 fatty liver disease Diseases 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 239000012530 fluid Substances 0.000 description 2
- 210000004051 gastric juice Anatomy 0.000 description 2
- 238000003304 gavage Methods 0.000 description 2
- 229910052732 germanium Inorganic materials 0.000 description 2
- GNPVGFCGXDBREM-UHFFFAOYSA-N germanium atom Chemical compound [Ge] GNPVGFCGXDBREM-UHFFFAOYSA-N 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229940093915 gynecological organic acid Drugs 0.000 description 2
- 231100000869 headache Toxicity 0.000 description 2
- 229910001385 heavy metal Inorganic materials 0.000 description 2
- 230000011132 hemopoiesis Effects 0.000 description 2
- 208000014617 hemorrhoid Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 210000004024 hepatic stellate cell Anatomy 0.000 description 2
- VUYDGVRIQRPHFX-UHFFFAOYSA-N hesperidin Natural products COc1cc(ccc1O)C2CC(=O)c3c(O)cc(OC4OC(COC5OC(O)C(O)C(O)C5O)C(O)C(O)C4O)cc3O2 VUYDGVRIQRPHFX-UHFFFAOYSA-N 0.000 description 2
- 229960001340 histamine Drugs 0.000 description 2
- 230000003054 hormonal effect Effects 0.000 description 2
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 2
- 201000001421 hyperglycemia Diseases 0.000 description 2
- 102000018358 immunoglobulin Human genes 0.000 description 2
- 201000001881 impotence Diseases 0.000 description 2
- 230000001965 increasing effect Effects 0.000 description 2
- 229940102223 injectable solution Drugs 0.000 description 2
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
- 239000002085 irritant Substances 0.000 description 2
- 235000021374 legumes Nutrition 0.000 description 2
- 231100000518 lethal Toxicity 0.000 description 2
- 230000001665 lethal effect Effects 0.000 description 2
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 2
- 201000007270 liver cancer Diseases 0.000 description 2
- 208000014018 liver neoplasm Diseases 0.000 description 2
- 210000004698 lymphocyte Anatomy 0.000 description 2
- 210000002540 macrophage Anatomy 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 239000000401 methanolic extract Substances 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 230000000116 mitigating effect Effects 0.000 description 2
- 210000003205 muscle Anatomy 0.000 description 2
- 230000002107 myocardial effect Effects 0.000 description 2
- 231100000252 nontoxic Toxicity 0.000 description 2
- 230000003000 nontoxic effect Effects 0.000 description 2
- 230000000050 nutritive effect Effects 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 235000005985 organic acids Nutrition 0.000 description 2
- LPMXVESGRSUGHW-HBYQJFLCSA-N ouabain Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1C[C@@]2(O)CC[C@H]3[C@@]4(O)CC[C@H](C=5COC(=O)C=5)[C@@]4(C)C[C@@H](O)[C@@H]3[C@@]2(CO)[C@H](O)C1 LPMXVESGRSUGHW-HBYQJFLCSA-N 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 244000052769 pathogen Species 0.000 description 2
- 230000008855 peristalsis Effects 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 231100000572 poisoning Toxicity 0.000 description 2
- 230000000607 poisoning effect Effects 0.000 description 2
- 230000005195 poor health Effects 0.000 description 2
- 239000011148 porous material Substances 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- BBEAQIROQSPTKN-UHFFFAOYSA-N pyrene Chemical compound C1=CC=C2C=CC3=CC=CC4=CC=C1C2=C43 BBEAQIROQSPTKN-UHFFFAOYSA-N 0.000 description 2
- 230000000171 quenching effect Effects 0.000 description 2
- 206010037844 rash Diseases 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000003014 reinforcing effect Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000005070 ripening Effects 0.000 description 2
- 230000036280 sedation Effects 0.000 description 2
- 229940007046 shigella dysenteriae Drugs 0.000 description 2
- 201000005113 shigellosis Diseases 0.000 description 2
- 239000007787 solid Substances 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 210000003802 sputum Anatomy 0.000 description 2
- 208000024794 sputum Diseases 0.000 description 2
- 238000010025 steaming Methods 0.000 description 2
- 231100000240 steatosis hepatitis Toxicity 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000004659 sterilization and disinfection Methods 0.000 description 2
- 229930002534 steroid glycoside Natural products 0.000 description 2
- 230000004206 stomach function Effects 0.000 description 2
- QMGVPVSNSZLJIA-FVWCLLPLSA-N strychnine Chemical compound O([C@H]1CC(N([C@H]2[C@H]1[C@H]1C3)C=4C5=CC=CC=4)=O)CC=C1CN1[C@@H]3[C@]25CC1 QMGVPVSNSZLJIA-FVWCLLPLSA-N 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 230000004083 survival effect Effects 0.000 description 2
- 210000004243 sweat Anatomy 0.000 description 2
- 229960000716 tonics Drugs 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- 230000001052 transient effect Effects 0.000 description 2
- 230000008736 traumatic injury Effects 0.000 description 2
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 description 2
- 150000003648 triterpenes Chemical class 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
- 230000003612 virological effect Effects 0.000 description 2
- 210000001835 viscera Anatomy 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- JLTCWSBVQSZVLT-CDIPANDDSA-N (2s)-n-[(2s)-6-amino-1-[(2-amino-2-oxoethyl)amino]-1-oxohexan-2-yl]-1-[(4r,7s,10s,13s,16s,19r)-19-amino-7-(2-amino-2-oxoethyl)-10-(3-amino-3-oxopropyl)-13-benzyl-16-[(4-hydroxyphenyl)methyl]-6,9,12,15,18-pentaoxo-1,2-dithia-5,8,11,14,17-pentazacycloicosan Chemical compound NCCCC[C@@H](C(=O)NCC(N)=O)NC(=O)[C@@H]1CCCN1C(=O)[C@H]1NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC=2C=CC(O)=CC=2)NC(=O)[C@@H](N)CSSC1.C([C@H]1C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CSSC[C@@H](C(N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N1)=O)N)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCN=C(N)N)C(=O)NCC(N)=O)C1=CC=CC=C1 JLTCWSBVQSZVLT-CDIPANDDSA-N 0.000 description 1
- 239000001490 (3R)-3,7-dimethylocta-1,6-dien-3-ol Substances 0.000 description 1
- BHQCQFFYRZLCQQ-UHFFFAOYSA-N (3alpha,5alpha,7alpha,12alpha)-3,7,12-trihydroxy-cholan-24-oic acid Natural products OC1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 BHQCQFFYRZLCQQ-UHFFFAOYSA-N 0.000 description 1
- UUTKICFRNVKFRG-WDSKDSINSA-N (4R)-3-[oxo-[(2S)-5-oxo-2-pyrrolidinyl]methyl]-4-thiazolidinecarboxylic acid Chemical compound OC(=O)[C@@H]1CSCN1C(=O)[C@H]1NC(=O)CC1 UUTKICFRNVKFRG-WDSKDSINSA-N 0.000 description 1
- OYHQOLUKZRVURQ-NTGFUMLPSA-N (9Z,12Z)-9,10,12,13-tetratritiooctadeca-9,12-dienoic acid Chemical compound C(CCCCCCC\C(=C(/C\C(=C(/CCCCC)\[3H])\[3H])\[3H])\[3H])(=O)O OYHQOLUKZRVURQ-NTGFUMLPSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- CDOSHBSSFJOMGT-JTQLQIEISA-N (R)-linalool Natural products CC(C)=CCC[C@@](C)(O)C=C CDOSHBSSFJOMGT-JTQLQIEISA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- JBDOSUUXMYMWQH-UHFFFAOYSA-N 1-naphthyl isothiocyanate Chemical compound C1=CC=C2C(N=C=S)=CC=CC2=C1 JBDOSUUXMYMWQH-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-GASJEMHNSA-N 2-amino-2-deoxy-D-galactopyranose Chemical compound N[C@H]1C(O)O[C@H](CO)[C@H](O)[C@@H]1O MSWZFWKMSRAUBD-GASJEMHNSA-N 0.000 description 1
- ZSLUVFAKFWKJRC-IGMARMGPSA-N 232Th Chemical compound [232Th] ZSLUVFAKFWKJRC-IGMARMGPSA-N 0.000 description 1
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 1
- 208000030507 AIDS Diseases 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 206010000060 Abdominal distension Diseases 0.000 description 1
- 206010049865 Achromotrichia acquired Diseases 0.000 description 1
- 208000030090 Acute Disease Diseases 0.000 description 1
- 241000206486 Adonis Species 0.000 description 1
- 241001552669 Adonis annua Species 0.000 description 1
- 206010001497 Agitation Diseases 0.000 description 1
- 206010001580 Albuminuria Diseases 0.000 description 1
- JDLKFOPOAOFWQN-VIFPVBQESA-N Allicin Natural products C=CCS[S@](=O)CC=C JDLKFOPOAOFWQN-VIFPVBQESA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 201000004384 Alopecia Diseases 0.000 description 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 description 1
- 240000001592 Amaranthus caudatus Species 0.000 description 1
- 244000144725 Amygdalus communis Species 0.000 description 1
- 235000011437 Amygdalus communis Nutrition 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 206010002091 Anaesthesia Diseases 0.000 description 1
- 241000256837 Apidae Species 0.000 description 1
- 241000256846 Apis cerana Species 0.000 description 1
- 241000256844 Apis mellifera Species 0.000 description 1
- 241000205585 Aquilegia canadensis Species 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 206010003658 Atrial Fibrillation Diseases 0.000 description 1
- 206010003671 Atrioventricular Block Diseases 0.000 description 1
- 208000004300 Atrophic Gastritis Diseases 0.000 description 1
- 229930003347 Atropine Natural products 0.000 description 1
- DBMJZOMNXBSRED-UHFFFAOYSA-N Bergamottin Natural products O1C(=O)C=CC2=C1C=C1OC=CC1=C2OCC=C(C)CCC=C(C)C DBMJZOMNXBSRED-UHFFFAOYSA-N 0.000 description 1
- 239000002126 C01EB10 - Adenosine Substances 0.000 description 1
- 241000282472 Canis lupus familiaris Species 0.000 description 1
- 241000131317 Capitulum Species 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 208000001378 Carbon Tetrachloride Poisoning Diseases 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000017897 Carcinoma of esophagus Diseases 0.000 description 1
- 206010007559 Cardiac failure congestive Diseases 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 241001107116 Castanospermum australe Species 0.000 description 1
- 241000700198 Cavia Species 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008111 Cerebral haemorrhage Diseases 0.000 description 1
- 206010008132 Cerebral thrombosis Diseases 0.000 description 1
- 206010008190 Cerebrovascular accident Diseases 0.000 description 1
- 229910052684 Cerium Inorganic materials 0.000 description 1
- 208000008964 Chemical and Drug Induced Liver Injury Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000331528 Chlorophytum capense Species 0.000 description 1
- 239000004380 Cholic acid Substances 0.000 description 1
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 235000008495 Chrysanthemum leucanthemum Nutrition 0.000 description 1
- 235000000604 Chrysanthemum parthenium Nutrition 0.000 description 1
- 241000931705 Cicada Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- 235000000228 Citrus myrtifolia Nutrition 0.000 description 1
- 235000016646 Citrus taiwanica Nutrition 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 206010009944 Colon cancer Diseases 0.000 description 1
- 206010010741 Conjunctivitis Diseases 0.000 description 1
- 208000034656 Contusions Diseases 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- KQLDDLUWUFBQHP-UHFFFAOYSA-N Cordycepin Natural products C1=NC=2C(N)=NC=NC=2N1C1OCC(CO)C1O KQLDDLUWUFBQHP-UHFFFAOYSA-N 0.000 description 1
- 241000190633 Cordyceps Species 0.000 description 1
- 241001573881 Corolla Species 0.000 description 1
- 241000186227 Corynebacterium diphtheriae Species 0.000 description 1
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 241000371652 Curvularia clavata Species 0.000 description 1
- 230000006820 DNA synthesis Effects 0.000 description 1
- 240000004585 Dactylis glomerata Species 0.000 description 1
- 206010011878 Deafness Diseases 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- RYAHJFGVOCZDEI-UFFNCVEVSA-N Dendrobine Chemical compound C([C@H]1CC[C@@H]2[C@@]31C)N(C)[C@@H]3[C@H]1[C@@H](C(C)C)[C@@H]2C(=O)O1 RYAHJFGVOCZDEI-UFFNCVEVSA-N 0.000 description 1
- 206010012335 Dependence Diseases 0.000 description 1
- 206010012434 Dermatitis allergic Diseases 0.000 description 1
- 241000219764 Dolichos Species 0.000 description 1
- 206010013789 Dry throat Diseases 0.000 description 1
- 206010013911 Dysgeusia Diseases 0.000 description 1
- 206010013935 Dysmenorrhoea Diseases 0.000 description 1
- 208000005189 Embolism Diseases 0.000 description 1
- 241001465251 Ephedra sinica Species 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 241000588724 Escherichia coli Species 0.000 description 1
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 1
- 240000005066 Euchiton japonicus Species 0.000 description 1
- YCKRFDGAMUMZLT-UHFFFAOYSA-N Fluorine atom Chemical compound [F] YCKRFDGAMUMZLT-UHFFFAOYSA-N 0.000 description 1
- 208000001034 Frostbite Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 241000287828 Gallus gallus Species 0.000 description 1
- 102100035695 Gamma-aminobutyric acid receptor-associated protein Human genes 0.000 description 1
- 241001149422 Ganoderma applanatum Species 0.000 description 1
- 241001489100 Ganoderma capense Species 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000036495 Gastritis atrophic Diseases 0.000 description 1
- 241000726221 Gemma Species 0.000 description 1
- 239000005792 Geraniol Substances 0.000 description 1
- GLZPCOQZEFWAFX-YFHOEESVSA-N Geraniol Natural products CC(C)=CCC\C(C)=C/CO GLZPCOQZEFWAFX-YFHOEESVSA-N 0.000 description 1
- 208000010412 Glaucoma Diseases 0.000 description 1
- 206010018367 Glomerulonephritis chronic Diseases 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 241000202807 Glycyrrhiza Species 0.000 description 1
- 235000001453 Glycyrrhiza echinata Nutrition 0.000 description 1
- 244000303040 Glycyrrhiza glabra Species 0.000 description 1
- 235000006200 Glycyrrhiza glabra Nutrition 0.000 description 1
- 235000017382 Glycyrrhiza lepidota Nutrition 0.000 description 1
- 206010018910 Haemolysis Diseases 0.000 description 1
- 206010062713 Haemorrhagic diathesis Diseases 0.000 description 1
- 206010061192 Haemorrhagic fever Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010061998 Hepatic lesion Diseases 0.000 description 1
- 206010049077 Hernia pain Diseases 0.000 description 1
- 208000031361 Hiccup Diseases 0.000 description 1
- 101001001372 Homo sapiens Gamma-aminobutyric acid receptor-associated protein Proteins 0.000 description 1
- 241001632576 Hyacinthus Species 0.000 description 1
- 108010003272 Hyaluronate lyase Proteins 0.000 description 1
- 102000001974 Hyaluronidases Human genes 0.000 description 1
- RKUNBYITZUJHSG-UHFFFAOYSA-N Hyosciamin-hydrochlorid Natural products CN1C(C2)CCC1CC2OC(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-UHFFFAOYSA-N 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 206010021143 Hypoxia Diseases 0.000 description 1
- 206010061216 Infarction Diseases 0.000 description 1
- 206010061218 Inflammation Diseases 0.000 description 1
- 102000004877 Insulin Human genes 0.000 description 1
- 108090001061 Insulin Proteins 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- ZUKLFFYDSALIQW-MSUKCBDUSA-N Iridoid glycoside Chemical compound [H][C@]12CC[C@H](C(O)=O)[C@@]1([H])[C@H](OC1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O)OC=C2 ZUKLFFYDSALIQW-MSUKCBDUSA-N 0.000 description 1
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 1
- 240000006859 Jasminum officinale Species 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 241000758791 Juglandaceae Species 0.000 description 1
- 241000366676 Justicia pectoralis Species 0.000 description 1
- 208000019926 Keshan disease Diseases 0.000 description 1
- 241000207923 Lamiaceae Species 0.000 description 1
- 241000112528 Ligusticum striatum Species 0.000 description 1
- 239000004367 Lipase Substances 0.000 description 1
- 102000004882 Lipase Human genes 0.000 description 1
- 108090001060 Lipase Proteins 0.000 description 1
- 102000004895 Lipoproteins Human genes 0.000 description 1
- 108090001030 Lipoproteins Proteins 0.000 description 1
- 208000015924 Lithiasis Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 206010058467 Lung neoplasm malignant Diseases 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 244000241872 Lycium chinense Species 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 244000024873 Mentha crispa Species 0.000 description 1
- 244000078639 Mentha spicata Species 0.000 description 1
- 241000237852 Mollusca Species 0.000 description 1
- ZOKXTWBITQBERF-UHFFFAOYSA-N Molybdenum Chemical compound [Mo] ZOKXTWBITQBERF-UHFFFAOYSA-N 0.000 description 1
- 101100042796 Mus musculus Smc2 gene Proteins 0.000 description 1
- 241000187479 Mycobacterium tuberculosis Species 0.000 description 1
- 206010029240 Neuritis Diseases 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 206010059013 Nocturnal emission Diseases 0.000 description 1
- QMGVPVSNSZLJIA-UHFFFAOYSA-N Nux Vomica Natural products C1C2C3C4N(C=5C6=CC=CC=5)C(=O)CC3OCC=C2CN2C1C46CC2 QMGVPVSNSZLJIA-UHFFFAOYSA-N 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 241000565675 Oncomelania Species 0.000 description 1
- 235000019082 Osmanthus Nutrition 0.000 description 1
- 241000333181 Osmanthus Species 0.000 description 1
- 206010033128 Ovarian cancer Diseases 0.000 description 1
- 206010061535 Ovarian neoplasm Diseases 0.000 description 1
- 241000904014 Pappus Species 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- 241000287127 Passeridae Species 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 241000207960 Pedaliaceae Species 0.000 description 1
- 208000008469 Peptic Ulcer Diseases 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 102000003992 Peroxidases Human genes 0.000 description 1
- 201000005702 Pertussis Diseases 0.000 description 1
- 241001522129 Pinellia Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 208000037062 Polyps Diseases 0.000 description 1
- 235000000404 Poncirus trifoliata Nutrition 0.000 description 1
- 244000202052 Poncirus trifoliata Species 0.000 description 1
- 102000005320 Posterior Pituitary Hormones Human genes 0.000 description 1
- 108010070873 Posterior Pituitary Hormones Proteins 0.000 description 1
- 206010036590 Premature baby Diseases 0.000 description 1
- 208000012287 Prolapse Diseases 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 240000005049 Prunus salicina Species 0.000 description 1
- 208000003251 Pruritus Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 241000219780 Pueraria Species 0.000 description 1
- ZVOLCUVKHLEPEV-UHFFFAOYSA-N Quercetagetin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=C(O)C(O)=C(O)C=C2O1 ZVOLCUVKHLEPEV-UHFFFAOYSA-N 0.000 description 1
- LUJAXSNNYBCFEE-UHFFFAOYSA-N Quercetin 3,7-dimethyl ether Natural products C=1C(OC)=CC(O)=C(C(C=2OC)=O)C=1OC=2C1=CC=C(O)C(O)=C1 LUJAXSNNYBCFEE-UHFFFAOYSA-N 0.000 description 1
- PUTDIROJWHRSJW-UHFFFAOYSA-N Quercitrin Natural products CC1OC(Oc2cc(cc(O)c2O)C3=CC(=O)c4c(O)cc(O)cc4O3)C(O)C(O)C1O PUTDIROJWHRSJW-UHFFFAOYSA-N 0.000 description 1
- 230000006819 RNA synthesis Effects 0.000 description 1
- 244000088415 Raphanus sativus Species 0.000 description 1
- 235000006140 Raphanus sativus var sativus Nutrition 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 208000025747 Rheumatic disease Diseases 0.000 description 1
- HWTZYBCRDDUBJY-UHFFFAOYSA-N Rhynchosin Natural products C1=C(O)C(O)=CC=C1C1=C(O)C(=O)C2=CC(O)=C(O)C=C2O1 HWTZYBCRDDUBJY-UHFFFAOYSA-N 0.000 description 1
- 240000001890 Ribes hudsonianum Species 0.000 description 1
- 235000016954 Ribes hudsonianum Nutrition 0.000 description 1
- 235000001466 Ribes nigrum Nutrition 0.000 description 1
- 241000220222 Rosaceae Species 0.000 description 1
- 241001107098 Rubiaceae Species 0.000 description 1
- 241001442514 Schistosomatidae Species 0.000 description 1
- 241000239226 Scorpiones Species 0.000 description 1
- 240000005319 Sedum acre Species 0.000 description 1
- 235000014327 Sedum acre Nutrition 0.000 description 1
- 206010070834 Sensitisation Diseases 0.000 description 1
- 241000238370 Sepia Species 0.000 description 1
- 240000005498 Setaria italica Species 0.000 description 1
- 235000007226 Setaria italica Nutrition 0.000 description 1
- 206010040904 Skin odour abnormal Diseases 0.000 description 1
- 208000032140 Sleepiness Diseases 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 206010041349 Somnolence Diseases 0.000 description 1
- 208000005392 Spasm Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 206010042220 Stress ulcer Diseases 0.000 description 1
- 208000006011 Stroke Diseases 0.000 description 1
- 241001279009 Strychnos toxifera Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 239000005864 Sulphur Substances 0.000 description 1
- 240000004460 Tanacetum coccineum Species 0.000 description 1
- 206010053615 Thermal burn Diseases 0.000 description 1
- 229910052776 Thorium Inorganic materials 0.000 description 1
- 206010043561 Thrombocytopenic purpura Diseases 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- 240000006909 Tilia x europaea Species 0.000 description 1
- 208000009205 Tinnitus Diseases 0.000 description 1
- 102000003929 Transaminases Human genes 0.000 description 1
- 108090000340 Transaminases Proteins 0.000 description 1
- 102000004357 Transferases Human genes 0.000 description 1
- 108090000992 Transferases Proteins 0.000 description 1
- 206010044565 Tremor Diseases 0.000 description 1
- 208000037386 Typhoid Diseases 0.000 description 1
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
- 208000024780 Urticaria Diseases 0.000 description 1
- 206010047513 Vision blurred Diseases 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 241001251949 Xanthium sibiricum Species 0.000 description 1
- 101100095967 Xenopus laevis smc2 gene Proteins 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- XYUNNDAEUQFHGV-UHFFFAOYSA-N [Se].[Se] Chemical compound [Se].[Se] XYUNNDAEUQFHGV-UHFFFAOYSA-N 0.000 description 1
- 208000019790 abdominal distention Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- OXGUCUVFOIWWQJ-XIMSSLRFSA-N acanthophorin B Natural products O[C@H]1[C@H](O)[C@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-XIMSSLRFSA-N 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000021736 acetylation Effects 0.000 description 1
- 238000006640 acetylation reaction Methods 0.000 description 1
- 230000003504 ach effect Effects 0.000 description 1
- 230000003213 activating effect Effects 0.000 description 1
- 201000004484 acute conjunctivitis Diseases 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 208000005298 acute pain Diseases 0.000 description 1
- 229960005305 adenosine Drugs 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 230000037006 agalactosis Effects 0.000 description 1
- 230000001476 alcoholic effect Effects 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- 230000000172 allergic effect Effects 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- JDLKFOPOAOFWQN-UHFFFAOYSA-N allicin Chemical compound C=CCSS(=O)CC=C JDLKFOPOAOFWQN-UHFFFAOYSA-N 0.000 description 1
- 235000010081 allicin Nutrition 0.000 description 1
- 235000020224 almond Nutrition 0.000 description 1
- 231100000360 alopecia Toxicity 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 239000004178 amaranth Substances 0.000 description 1
- 235000012735 amaranth Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000037005 anaesthesia Effects 0.000 description 1
- 238000001949 anaesthesia Methods 0.000 description 1
- 230000036592 analgesia Effects 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000008485 antagonism Effects 0.000 description 1
- 230000003266 anti-allergic effect Effects 0.000 description 1
- 230000001078 anti-cholinergic effect Effects 0.000 description 1
- 230000001773 anti-convulsant effect Effects 0.000 description 1
- 230000002082 anti-convulsion Effects 0.000 description 1
- 230000002668 anti-heparin effect Effects 0.000 description 1
- 230000000845 anti-microbial effect Effects 0.000 description 1
- 230000002460 anti-migrenic effect Effects 0.000 description 1
- 230000000702 anti-platelet effect Effects 0.000 description 1
- 230000003005 anti-senility effect Effects 0.000 description 1
- 239000003146 anticoagulant agent Substances 0.000 description 1
- 230000010100 anticoagulation Effects 0.000 description 1
- 239000000427 antigen Substances 0.000 description 1
- 230000000890 antigenic effect Effects 0.000 description 1
- 102000036639 antigens Human genes 0.000 description 1
- 108091007433 antigens Proteins 0.000 description 1
- 210000000436 anus Anatomy 0.000 description 1
- 230000004596 appetite loss Effects 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 208000011775 arteriosclerosis disease Diseases 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 201000008937 atopic dermatitis Diseases 0.000 description 1
- RKUNBYITZUJHSG-SPUOUPEWSA-N atropine Chemical compound O([C@H]1C[C@H]2CC[C@@H](C1)N2C)C(=O)C(CO)C1=CC=CC=C1 RKUNBYITZUJHSG-SPUOUPEWSA-N 0.000 description 1
- 229960000396 atropine Drugs 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 230000002567 autonomic effect Effects 0.000 description 1
- WDIHJSXYQDMJHN-UHFFFAOYSA-L barium chloride Chemical compound [Cl-].[Cl-].[Ba+2] WDIHJSXYQDMJHN-UHFFFAOYSA-L 0.000 description 1
- 229910001626 barium chloride Inorganic materials 0.000 description 1
- 238000009412 basement excavation Methods 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 229960002045 bergapten Drugs 0.000 description 1
- KGZDKFWCIPZMRK-UHFFFAOYSA-N bergapten Natural products COC1C2=C(Cc3ccoc13)C=CC(=O)O2 KGZDKFWCIPZMRK-UHFFFAOYSA-N 0.000 description 1
- MSWZFWKMSRAUBD-UHFFFAOYSA-N beta-D-galactosamine Natural products NC1C(O)OC(CO)C(O)C1O MSWZFWKMSRAUBD-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 210000003445 biliary tract Anatomy 0.000 description 1
- 230000000975 bioactive effect Effects 0.000 description 1
- 239000003181 biological factor Substances 0.000 description 1
- 230000033558 biomineral tissue development Effects 0.000 description 1
- 235000021279 black bean Nutrition 0.000 description 1
- 235000007215 black sesame Nutrition 0.000 description 1
- 230000004531 blood pressure lowering effect Effects 0.000 description 1
- 210000001185 bone marrow Anatomy 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 235000008429 bread Nutrition 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 208000034526 bruise Diseases 0.000 description 1
- 229960001948 caffeine Drugs 0.000 description 1
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 1
- 229960005069 calcium Drugs 0.000 description 1
- 230000005907 cancer growth Effects 0.000 description 1
- 230000000711 cancerogenic effect Effects 0.000 description 1
- 208000020670 canker sore Diseases 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 231100000315 carcinogenic Toxicity 0.000 description 1
- 230000005961 cardioprotection Effects 0.000 description 1
- 210000001715 carotid artery Anatomy 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 230000001413 cellular effect Effects 0.000 description 1
- 210000003169 central nervous system Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- ZMIGMASIKSOYAM-UHFFFAOYSA-N cerium Chemical compound [Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce][Ce] ZMIGMASIKSOYAM-UHFFFAOYSA-N 0.000 description 1
- 229910052729 chemical element Inorganic materials 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- ZPEIMTDSQAKGNT-UHFFFAOYSA-N chlorpromazine Chemical compound C1=C(Cl)C=C2N(CCCN(C)C)C3=CC=CC=C3SC2=C1 ZPEIMTDSQAKGNT-UHFFFAOYSA-N 0.000 description 1
- 229960001076 chlorpromazine Drugs 0.000 description 1
- 201000001883 cholelithiasis Diseases 0.000 description 1
- BHQCQFFYRZLCQQ-OELDTZBJSA-N cholic acid Chemical compound C([C@H]1C[C@H]2O)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 BHQCQFFYRZLCQQ-OELDTZBJSA-N 0.000 description 1
- 235000019416 cholic acid Nutrition 0.000 description 1
- 229960002471 cholic acid Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 239000000812 cholinergic antagonist Substances 0.000 description 1
- 229940107218 chromium Drugs 0.000 description 1
- 208000016644 chronic atrophic gastritis Diseases 0.000 description 1
- 208000013116 chronic cough Diseases 0.000 description 1
- 208000023652 chronic gastritis Diseases 0.000 description 1
- 231100000749 chronicity Toxicity 0.000 description 1
- 235000019504 cigarettes Nutrition 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 210000001072 colon Anatomy 0.000 description 1
- 208000029742 colonic neoplasm Diseases 0.000 description 1
- 210000001953 common bile duct Anatomy 0.000 description 1
- 201000004196 common wart Diseases 0.000 description 1
- 230000002860 competitive effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 239000000039 congener Substances 0.000 description 1
- 210000000795 conjunctiva Anatomy 0.000 description 1
- 239000000470 constituent Substances 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- OFEZSBMBBKLLBJ-BAJZRUMYSA-N cordycepin Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)C[C@H]1O OFEZSBMBBKLLBJ-BAJZRUMYSA-N 0.000 description 1
- OFEZSBMBBKLLBJ-UHFFFAOYSA-N cordycepine Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)CC1O OFEZSBMBBKLLBJ-UHFFFAOYSA-N 0.000 description 1
- 210000004087 cornea Anatomy 0.000 description 1
- 239000003218 coronary vasodilator agent Substances 0.000 description 1
- 210000004351 coronary vessel Anatomy 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 210000000695 crystalline len Anatomy 0.000 description 1
- WTYGAUXICFETTC-UHFFFAOYSA-N cyclobarbital Chemical compound C=1CCCCC=1C1(CC)C(=O)NC(=O)NC1=O WTYGAUXICFETTC-UHFFFAOYSA-N 0.000 description 1
- 230000000120 cytopathologic effect Effects 0.000 description 1
- 210000003785 decidua Anatomy 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 230000007850 degeneration Effects 0.000 description 1
- 238000005238 degreasing Methods 0.000 description 1
- 230000036425 denaturation Effects 0.000 description 1
- 238000004925 denaturation Methods 0.000 description 1
- RYAHJFGVOCZDEI-CZKZLRAZSA-N dendrobine Natural products O=C1O[C@@H]2[C@H](C(C)C)[C@H]1[C@H]1[C@@]3(C)[C@@H]2N(C)C[C@H]3CC1 RYAHJFGVOCZDEI-CZKZLRAZSA-N 0.000 description 1
- KXGVEGMKQFWNSR-UHFFFAOYSA-N deoxycholic acid Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(CCC(O)=O)C)C1(C)C(O)C2 KXGVEGMKQFWNSR-UHFFFAOYSA-N 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- XEYBRNLFEZDVAW-ARSRFYASSA-N dinoprostone Chemical compound CCCCC[C@H](O)\C=C\[C@H]1[C@H](O)CC(=O)[C@@H]1C\C=C/CCCC(O)=O XEYBRNLFEZDVAW-ARSRFYASSA-N 0.000 description 1
- 229960002986 dinoprostone Drugs 0.000 description 1
- ZZVUWRFHKOJYTH-UHFFFAOYSA-N diphenhydramine Chemical compound C=1C=CC=CC=1C(OCCN(C)C)C1=CC=CC=C1 ZZVUWRFHKOJYTH-UHFFFAOYSA-N 0.000 description 1
- 229960000520 diphenhydramine Drugs 0.000 description 1
- RMDMBHQVNHQDDD-VFWKRBOSSA-L disodium;(2e,4e,6e,8e,10e,12e,14e)-2,6,11,15-tetramethylhexadeca-2,4,6,8,10,12,14-heptaenedioate Chemical compound [Na+].[Na+].[O-]C(=O)C(/C)=C/C=C/C(/C)=C/C=C/C=C(\C)/C=C/C=C(\C)C([O-])=O RMDMBHQVNHQDDD-VFWKRBOSSA-L 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 238000001647 drug administration Methods 0.000 description 1
- 230000000857 drug effect Effects 0.000 description 1
- 230000002183 duodenal effect Effects 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 210000001198 duodenum Anatomy 0.000 description 1
- 244000013123 dwarf bean Species 0.000 description 1
- 230000004064 dysfunction Effects 0.000 description 1
- 235000018927 edible plant Nutrition 0.000 description 1
- 230000003073 embolic effect Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000001037 epileptic effect Effects 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000020776 essential amino acid Nutrition 0.000 description 1
- 239000003797 essential amino acid Substances 0.000 description 1
- 239000000469 ethanolic extract Substances 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 238000009313 farming Methods 0.000 description 1
- 210000003608 fece Anatomy 0.000 description 1
- 235000008384 feverfew Nutrition 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 125000004387 flavanoid group Chemical group 0.000 description 1
- 229930003949 flavanone Natural products 0.000 description 1
- 150000002208 flavanones Chemical class 0.000 description 1
- 235000011981 flavanones Nutrition 0.000 description 1
- HVQAJTFOCKOKIN-UHFFFAOYSA-N flavonol Natural products O1C2=CC=CC=C2C(=O)C(O)=C1C1=CC=CC=C1 HVQAJTFOCKOKIN-UHFFFAOYSA-N 0.000 description 1
- 150000002216 flavonol derivatives Chemical class 0.000 description 1
- 235000011957 flavonols Nutrition 0.000 description 1
- 235000013312 flour Nutrition 0.000 description 1
- GVEPBJHOBDJJJI-UHFFFAOYSA-N fluoranthrene Natural products C1=CC(C2=CC=CC=C22)=C3C2=CC=CC3=C1 GVEPBJHOBDJJJI-UHFFFAOYSA-N 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000004345 fruit ripening Effects 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 229940113087 geraniol Drugs 0.000 description 1
- 230000035784 germination Effects 0.000 description 1
- 238000005247 gettering Methods 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 244000237330 gutta percha tree Species 0.000 description 1
- 230000002650 habitual effect Effects 0.000 description 1
- 230000003394 haemopoietic effect Effects 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 208000019622 heart disease Diseases 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000008588 hemolysis Effects 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 208000031169 hemorrhagic disease Diseases 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 210000003494 hepatocyte Anatomy 0.000 description 1
- 235000008216 herbs Nutrition 0.000 description 1
- 230000010196 hermaphroditism Effects 0.000 description 1
- 208000023513 hiccough Diseases 0.000 description 1
- 208000021760 high fever Diseases 0.000 description 1
- 210000001624 hip Anatomy 0.000 description 1
- 230000036732 histological change Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 235000003642 hunger Nutrition 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 229960002773 hyaluronidase Drugs 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000002432 hydroperoxides Chemical class 0.000 description 1
- 230000007954 hypoxia Effects 0.000 description 1
- 210000003405 ileum Anatomy 0.000 description 1
- 230000002519 immonomodulatory effect Effects 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 230000016784 immunoglobulin production Effects 0.000 description 1
- 230000004377 improving vision Effects 0.000 description 1
- 230000007574 infarction Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 210000004969 inflammatory cell Anatomy 0.000 description 1
- 230000004054 inflammatory process Effects 0.000 description 1
- 206010022000 influenza Diseases 0.000 description 1
- 238000001802 infusion Methods 0.000 description 1
- 229940125396 insulin Drugs 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- ICIWUVCWSCSTAQ-UHFFFAOYSA-M iodate Chemical compound [O-]I(=O)=O ICIWUVCWSCSTAQ-UHFFFAOYSA-M 0.000 description 1
- LTINPJMVDKPJJI-UHFFFAOYSA-N iodinated glycerol Chemical compound CC(I)C1OCC(CO)O1 LTINPJMVDKPJJI-UHFFFAOYSA-N 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 229930182489 iridoid glycoside Natural products 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- 239000010977 jade Substances 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- MWDZOUNAPSSOEL-UHFFFAOYSA-N kaempferol Natural products OC1=C(C(=O)c2cc(O)cc(O)c2O1)c3ccc(O)cc3 MWDZOUNAPSSOEL-UHFFFAOYSA-N 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000003127 knee Anatomy 0.000 description 1
- 210000000629 knee joint Anatomy 0.000 description 1
- 150000002596 lactones Chemical class 0.000 description 1
- 239000008141 laxative Substances 0.000 description 1
- 230000002475 laxative effect Effects 0.000 description 1
- 238000002386 leaching Methods 0.000 description 1
- 239000010985 leather Substances 0.000 description 1
- 208000032839 leukemia Diseases 0.000 description 1
- 201000005630 leukorrhea Diseases 0.000 description 1
- 229940010454 licorice Drugs 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- 229930007744 linalool Natural products 0.000 description 1
- 235000019421 lipase Nutrition 0.000 description 1
- 239000002502 liposome Substances 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 208000019017 loss of appetite Diseases 0.000 description 1
- 235000021266 loss of appetite Nutrition 0.000 description 1
- 201000005202 lung cancer Diseases 0.000 description 1
- 208000020816 lung neoplasm Diseases 0.000 description 1
- 210000002751 lymph Anatomy 0.000 description 1
- 201000007227 lymph node tuberculosis Diseases 0.000 description 1
- 239000009064 mailuoning Substances 0.000 description 1
- 239000002075 main ingredient Substances 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 210000001161 mammalian embryo Anatomy 0.000 description 1
- 210000001595 mastoid Anatomy 0.000 description 1
- 230000035800 maturation Effects 0.000 description 1
- 230000010534 mechanism of action Effects 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- LGZXYFMMLRYXLK-UHFFFAOYSA-N mercury(2+);sulfide Chemical compound [S-2].[Hg+2] LGZXYFMMLRYXLK-UHFFFAOYSA-N 0.000 description 1
- 230000007102 metabolic function Effects 0.000 description 1
- 231100000783 metal toxicity Toxicity 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229910052750 molybdenum Inorganic materials 0.000 description 1
- 239000011733 molybdenum Substances 0.000 description 1
- 230000003680 myocardial damage Effects 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 210000000651 myofibroblast Anatomy 0.000 description 1
- 230000001114 myogenic effect Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 210000000822 natural killer cell Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 208000004296 neuralgia Diseases 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 238000010606 normalization Methods 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000014571 nuts Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000009965 odorless effect Effects 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 238000003305 oral gavage Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000008520 organization Effects 0.000 description 1
- 230000001151 other effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000004681 ovum Anatomy 0.000 description 1
- 230000004792 oxidative damage Effects 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 230000003071 parasitic effect Effects 0.000 description 1
- 230000001734 parasympathetic effect Effects 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 230000032696 parturition Effects 0.000 description 1
- 208000011906 peptic ulcer disease Diseases 0.000 description 1
- 230000002093 peripheral effect Effects 0.000 description 1
- 210000000578 peripheral nerve Anatomy 0.000 description 1
- 230000035699 permeability Effects 0.000 description 1
- 108040007629 peroxidase activity proteins Proteins 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229930015704 phenylpropanoid Natural products 0.000 description 1
- 230000000243 photosynthetic effect Effects 0.000 description 1
- 230000035479 physiological effects, processes and functions Effects 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 230000001863 plant nutrition Effects 0.000 description 1
- 235000021018 plums Nutrition 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 229910052573 porcelain Inorganic materials 0.000 description 1
- 210000003240 portal vein Anatomy 0.000 description 1
- 230000035935 pregnancy Effects 0.000 description 1
- MFDFERRIHVXMIY-UHFFFAOYSA-N procaine Chemical compound CCN(CC)CCOC(=O)C1=CC=C(N)C=C1 MFDFERRIHVXMIY-UHFFFAOYSA-N 0.000 description 1
- 229960004919 procaine Drugs 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- XEYBRNLFEZDVAW-UHFFFAOYSA-N prostaglandin E2 Natural products CCCCCC(O)C=CC1C(O)CC(=O)C1CC=CCCCC(O)=O XEYBRNLFEZDVAW-UHFFFAOYSA-N 0.000 description 1
- 208000018299 prostration Diseases 0.000 description 1
- 208000020016 psychiatric disease Diseases 0.000 description 1
- 230000005180 public health Effects 0.000 description 1
- 235000021251 pulses Nutrition 0.000 description 1
- NIFIFKQPDTWWGU-UHFFFAOYSA-N pyrite Chemical compound [Fe+2].[S-][S-] NIFIFKQPDTWWGU-UHFFFAOYSA-N 0.000 description 1
- 229910052683 pyrite Inorganic materials 0.000 description 1
- 239000011028 pyrite Substances 0.000 description 1
- 235000005875 quercetin Nutrition 0.000 description 1
- 229960001285 quercetin Drugs 0.000 description 1
- OEKUVLQNKPXSOY-UHFFFAOYSA-N quercetin 3-O-beta-D-glucopyranosyl(1->3)-alpha-L-rhamnopyranosyl(1->6)-beta-d-galactopyranoside Natural products OC1C(O)C(C(O)C)OC1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OEKUVLQNKPXSOY-UHFFFAOYSA-N 0.000 description 1
- QPHXPNUXTNHJOF-UHFFFAOYSA-N quercetin-7-O-beta-L-rhamnopyranoside Natural products OC1C(O)C(O)C(C)OC1OC1=CC(O)=C2C(=O)C(O)=C(C=3C=C(O)C(O)=CC=3)OC2=C1 QPHXPNUXTNHJOF-UHFFFAOYSA-N 0.000 description 1
- OXGUCUVFOIWWQJ-HQBVPOQASA-N quercitrin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1OC1=C(C=2C=C(O)C(O)=CC=2)OC2=CC(O)=CC(O)=C2C1=O OXGUCUVFOIWWQJ-HQBVPOQASA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 238000001959 radiotherapy Methods 0.000 description 1
- 230000009103 reabsorption Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000011514 reflex Effects 0.000 description 1
- 238000005057 refrigeration Methods 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 230000008439 repair process Effects 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000000552 rheumatic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 239000012266 salt solution Substances 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000003248 secreting effect Effects 0.000 description 1
- 230000008313 sensitization Effects 0.000 description 1
- 230000001568 sexual effect Effects 0.000 description 1
- ADZWSOLPGZMUMY-UHFFFAOYSA-M silver bromide Chemical compound [Ag]Br ADZWSOLPGZMUMY-UHFFFAOYSA-M 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 230000037321 sleepiness Effects 0.000 description 1
- 238000010583 slow cooling Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 210000002460 smooth muscle Anatomy 0.000 description 1
- 210000004872 soft tissue Anatomy 0.000 description 1
- 239000008247 solid mixture Substances 0.000 description 1
- 230000002048 spasmolytic effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004514 sphincter of oddi Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 230000004936 stimulating effect Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 229960005453 strychnine Drugs 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 150000003505 terpenes Chemical class 0.000 description 1
- 235000007586 terpenes Nutrition 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 230000002885 thrombogenetic effect Effects 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 231100000886 tinnitus Toxicity 0.000 description 1
- 230000000451 tissue damage Effects 0.000 description 1
- 231100000827 tissue damage Toxicity 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 210000003437 trachea Anatomy 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- 230000004102 tricarboxylic acid cycle Effects 0.000 description 1
- 230000001228 trophic effect Effects 0.000 description 1
- 230000010415 tropism Effects 0.000 description 1
- 210000004881 tumor cell Anatomy 0.000 description 1
- 230000004614 tumor growth Effects 0.000 description 1
- 201000008297 typhoid fever Diseases 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 229940116269 uric acid Drugs 0.000 description 1
- 150000007968 uric acids Chemical class 0.000 description 1
- 125000002220 ursolic acid group Chemical group 0.000 description 1
- 206010046901 vaginal discharge Diseases 0.000 description 1
- 210000001186 vagus nerve Anatomy 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- GPPXJZIENCGNKB-UHFFFAOYSA-N vanadium Chemical compound [V]#[V] GPPXJZIENCGNKB-UHFFFAOYSA-N 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 230000008728 vascular permeability Effects 0.000 description 1
- 230000024883 vasodilation Effects 0.000 description 1
- 230000017260 vegetative to reproductive phase transition of meristem Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 239000011800 void material Substances 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000009571 yupingfeng Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提供了一种适用于肝病患者的全营养配方食品,以富硒植物蛋白粉为主要营养成分,以富硒植物蛋白粉、黑芝麻和黑豆为主要营养成分,加入多种保肝护肝功能常用的中草药;加入低聚甘露糖有助于肠道吸收,对肠道吸收功能不好的中老年人群效果显著。本发明按常规方法制成粉剂长期服用,易于吸收。
Description
技术领域
本发明涉及食品加工技术领域,特别地,涉及一种适用于肝病患者的全营养配方食品。
背景技术
富硒食品就是富含微量元素硒的食品,一般分为天然富硒食品(又称植物活性硒食品),外源硒富硒食品(也称人工有机硒食品),比如黑山药、黑芝麻,黑豆,黑花生,黑米、大蒜等黑色食物都含有硒元素。
硒是人体必需的微量元素。硒参与合成人体内多种含硒酶和含硒蛋白。其中谷胱甘肽过氧化物酶,在生物体内催化氢过氧化物或脂质过氧化物转变为水或各种醇类,消除自由基对生物膜的攻击,保护生物膜免受氧化损伤;硒参与构成碘化甲状腺胺酸脱碘酶。国内市场上打着富硒旗号的食品有很多,但是每款产品的硒含量并没有明确的标注,这对消费者造成了很大的困扰,我到底要吃多少这样的食品,才能达到补硒的效果。
硒能提高人体免疫,促进淋巴细胞的增殖及抗体和免疫球蛋白的合成。硒对结肠癌、皮肤癌、肝癌、乳腺癌等多种癌症具有明显的抑制和防护的作用,其在机体内的中间代谢产物甲基烯醇具有较强的抗癌活性。硒与维生素E、大蒜素、亚油酸、锗、锌等营养素具有协同抗氧化的功效,增加抗氧化活性。同时,硒具有减轻和缓解重金属毒性的作用。
硒与它的同族元素硫相比,在地壳中的含量少得多。硒成单质存在的矿是极难找到的,全球唯一硒独立成矿的地区位于中国湖北恩施。
硒是从燃烧黄铁矿以制取硫酸的铅室中发现的,是贝齐里乌斯发现铈、钍后1817年发现的又一个化学元素。他命名这种新元素为selenium。他还发现到硒的同素异形体。他还原硒的氧化物,得到橙色无定形硒;缓慢冷却熔融的硒,得到灰色晶体硒;在空气中让硒化物自然分解,得到黑色晶体硒。
食物硒含量受地理影响很大,土壤硒的不同造成各地食品中硒含量的极大差异。土壤含硒量在0.4毫克/千克以上,就属于富硒土壤。我国72%的国土都属贫硒或缺硒土壤,长期摄入严重缺硒食品,必然会造成硒缺乏疾病。
中国营养学会对我国13个省市做过一项调查表明,成人日平均硒摄入量为26-32微克,离中国营养学会推荐的最低限度50微克相距甚远。一般植物性食品含硒量比较低,因此,开发经济、方便,适合长期食用的富硒食品已经势在必行。
发明内容
本发明目的在于提供一种适用于肝病患者的全营养配方食品,以解决技术问题。
一种适用于肝病患者的全营养配方食品,包括以下成分:石斛、山楂、灵芝、制黄精、木瓜、蜂胶、蒲公英、马齿苋、枳椇子、蛹虫草、决明子、黑芝麻、黑豆、谷芽、薄荷、芡实、莲子、麦芽、栀子、杭白菊、厚朴花、佛手、绿梅花、乌梅、玳玳花、佛手花、薏苡仁、扁豆、线叶金雀花、杜仲雄花、青钱柳叶、显齿蛇葡萄叶、裸藻、丹凤牡丹花、辣木叶、富硒植物蛋白粉、低聚甘露糖。
优选的,所述的适用于肝病患者的全营养配方食品,包括以下重量百分比的成分:石斛0.5-1%、山楂0.2-0.5%、灵芝1-2%、制黄精0.1-0.2%、木瓜0.2-0.5%、蜂胶0.1-0.3%、蒲公英0.5-1%、马齿苋1-2%、枳椇子2-3%、蛹虫草0.5-0.8%、决明子1-2%、黑芝麻8-15%、黑豆10-20%、谷芽2-3%、薄荷1-2%、芡实0.5-1%、莲子1-2%、麦芽0.5-1%、栀子1-2%、杭白菊1-2%、厚朴花2-3%、佛手0.5-1%、绿梅花1-2%、乌梅0.5-1%、玳玳花0.5-0.8%、佛手花0.2-0.5%、薏苡仁1-2%、扁豆1-2%、线叶金雀花1-2%、杜仲雄花1-1.5%、青钱柳叶0.2-0.5%、显齿蛇葡萄叶0.3-0.8%、裸藻0.2-0.4%、丹凤牡丹花0.1-0.3%、辣木叶2-3%、富硒植物蛋白粉30-50%和低聚甘露糖余量。
优选的,所述的适用于肝病患者的全营养配方食品,包括以下重量百分比的成分:石斛0.8%、山楂0.3%、灵芝1.5%、制黄精0.15%、木瓜0.35%、蜂胶0.2%、蒲公英0.7%、马齿苋1.2%、枳椇子2.5%、蛹虫草0.7%、决明子1.5%、黑芝麻12%、黑豆16%、谷芽2.8%、薄荷1.5%、芡实0.7%、莲子1.5%、麦芽0.8%、栀子1.4%、杭白菊1.6%、厚朴花2.2%、佛手0.8%、绿梅花1.5%、乌梅0.8%、玳玳花0.6%、佛手花0.4%、薏苡仁1.3%、扁豆1.5%、线叶金雀花1.6%、杜仲雄花1.3%、青钱柳叶0.4%、显齿蛇葡萄叶0.5%、裸藻0.3%、丹凤牡丹花0.2%、辣木叶2.4%、富硒植物蛋白粉35%和低聚甘露糖余量。
优选的,所述的富硒植物蛋白粉的硒含量是35-60mg/kg。
本发明的富硒植物蛋白粉,可以为富硒水稻蛋白粉、富硒小麦蛋白粉、富硒蔬菜蛋白粉或者富硒水果蛋白粉。
冬虫夏草又名虫草,是我国民间惯用的一种名贵滋补药材,其营养成分高于人参,可入药,也可食用,是上乘的佳肴,具有很高的营养价值。冬虫夏草可以增强机体的免疫力,滋补肺肾,对肺癌、肝癌等有明显的抑制作用。在临床上对肺虚久咳,气喘,肺结核咯血,盗汗,肾虚腰膝酸痛,阳痿遗精,神经衰弱及化疗、放疗后的红细胞下降都有疗效。
肝脏是人体消化系统中一个重要的消化腺分泌器官,对造血、解毒、脂肪的转化等都起到极其重要的作用,冬虫夏草对消化系统的作用就主要表现在对肝脏的一系列保护和防治上。
(1)冬虫夏草可改善患者肝功能,减轻肝脏的炎性细胞浸润和肝细胞变性坏死,虫草菌丝有较强的促肝细胞修复作用;
(2)虫草多糖脂质体(CPL)对CCl4损伤的肝组织有一定的保护作用;
(3)冬虫夏草水溶液能抑制肝储脂细胞增殖,还能抑制肝储脂细胞向肌纤维细胞及成纤维细胞转化。
石斛(学名:Dendrobium nobile Lindl),又名仙斛兰韵、不死草、还魂草、紫萦仙株、吊兰、林兰、禁生、金钗花等。茎直立,肉质状肥厚,稍扁的圆柱形,长10~60厘米,粗达1.3厘米。药用植物,性味甘淡微咸,寒,归胃、肾,肺经。益胃生津,滋阴清热。用于阴伤津亏,口干烦渴,食少干呕,病后虚热,目暗不明。石斛花姿优雅,玲珑可爱,花色鲜艳,气味芳香,被喻为“四大观赏洋花”之一。
古语有云“民以食为天”,所以健康养生当以膳食为主。唐朝开元年间的道家经典《道藏》称铁皮石斛为“九大仙草之首”。铁皮石斛最补血、精、津,令人精、气、神充足,在提高人体免疫力、抗衰老、降三高、防治糖尿病等方面都有显著的功效。用铁皮石斛入膳,能起到健康养生的效果。
石斛对肠管有兴奋作用,可使收缩幅度增加。药理试验表明,口服石斛煎剂能促进胃液分泌,帮助消化。石斛碱与非西汀药效相似而作用较弱,石斛浸膏能刺激小肠平滑肌的收缩,促进胃肠蠕动。石斛对慢性萎缩性胃炎能收到独特、满意的效果。
石斛含有酯类成分,具有活血化瘀、扩张血管及抗血小板凝结,治疗血栓闭塞脉搏管炎,脑血栓形成,动脉硬化性闭塞等作用。由石斛、金银花等药材提取加工的脉络宁注射液,有清热养阴、活血化瘀等功能。
灵芝(学名:Ganoderma Lucidum Karst),外形呈伞状,菌盖肾形、半圆形或近圆形,为多孔菌科真菌灵芝的子实体。具有补气安神、止咳平喘的功效,用于眩晕不眠、心悸气短、虚劳咳喘。灵芝已实现人工种植,其中以林中灵品质最佳,药用价值优于野生灵芝。
灵芝药用在我国已有2000多年的历史,被历代医药家视为滋补强壮、扶正固本的神奇珍品。2000年,已知灵芝属(Ganoderma)真菌约100余种,分布最广的为赤芝(G.lu-cidum),其次为紫芝(G.japonicum),还有树舌(G.applana-tum)、松杉灵芝(G.tsugae)和簿树芝(G.capense)等均供药用。经过大量临床研究,灵芝对神经衰弱、高脂血症、冠心病心绞痛、心律失常、克山病、高原不适症、肝炎、出血热、消化不良、气管炎等各有不同程度的疗效。需要注意的是,仅仅通过用灵芝食疗这种方法并不能起到明显的防治效果,建议可用决明子、黑乌龙等组方为决乌汤茶这种中医经典组方茶,对高血脂等症可以起到很好的防治效果。药理研究证明,灵芝有多方面的生物活性。
保肝解毒:灵芝对多种理化及生物因素引起的肝损伤有保护作用。无论在肝脏损害发生前还是发生后,服用灵芝都可保护肝脏,减轻肝损伤。灵芝还能促进肝脏对药物、毒物的代谢,对于中毒性肝炎有确切的疗效。尤其是慢性肝炎,灵芝可明显消除头晕、乏力、恶心、肝区不适等症状,并可有效地改善肝功能,使各项指标趋于正常。所以,灵芝可用于治疗慢性中毒、各类慢性肝炎、肝硬化、肝功能障碍。
治疗糖尿病:灵芝降血糖之原理是由于促进组织对糖的利用。服用灵芝后可取代胰岛素抑制脂肪酸的释出,可改善血糖、尿糖等症状。灵芝中的水溶性多糖,可减轻非胰岛素依赖型糖尿病的发病程度。
改善心血管系统:动物实验和临床试验均表明,灵芝可有效地扩张冠状动脉,增加冠脉血流量,改善心肌微循环,增强心肌氧和能量的供给,因此,对心肌缺血具有保护作用,可广泛用于冠心病、心绞痛等的治疗和预防。对高血脂病患者,灵芝可明显降低血胆固醇、脂蛋白和甘油三脂,并能预防动脉粥样硬化斑块的形成。对于粥样硬化斑块已经形成者,则有降低动脉壁胆固醇含量、软化血管、防止进一步损伤的作用。并可改善局部微循环,阻止血小板聚集。这些功效对于多种类型的中风有良好的防治作用。
肌肤美白:李时珍在《本草纲目》中就指出灵芝有“增智慧,好颜色”,灵芝是一种具有抗皱、消炎、清除色斑、保护皮肤。灵芝含有抑制黑色素的成分及多种对皮肤有益的微量元素等,这些成分能够通过减少人体自由基,加速细胞的再生,增加皮肤的厚度并增加胶原质,达到丰润皮肤、消除细纹与皱纹的效果。其中的多糖成分能够通过保持和调节皮肤水性,恢复皮肤弹性,使皮肤湿润、细腻。
蛹虫草-形态特征子座单生或数个一起从寄生蛹体的头部或节部长出,颜色为橘黄或橘红色,全长2-8厘米,蛹体颜色为紫色,长约1.5-2厘米。蛹虫草中的虫草素,可抗病毒、抗菌、明显抑制肿瘤生长、干扰人体RNA及DNA合成。蛹虫草富含虫草酸,虫草酸能有效预防治疗脑血栓、脑溢血、肾功能衰竭,同时还具有利尿作用。蛹虫草中的腺苷,可以抗病毒、抗菌,抑制血小板积聚防治血栓形成,还可消除面斑,抗衰防皱。蛹虫草中虫草多糖,有提高免疫力,延缓衰老,扶正固本,保护心脏、肝脏,抗痉的作用。蛹虫草中的麦角甾醇、超氧化物歧化酶,对抑制或消除催人衰老的超氧自由基形成及抗癌、防衰、减毒有良好作用。蛹虫草还富含硒,大量的科学实践证明硒可以明显地抑制癌细胞的生长,刺激免疫球蛋白和抗体的产生,增强机体免疫和抗氧化能力。
制黄精:用酒、黑豆同蒸后切片用,习称制黄精。黄精,在古代养生学家的眼中是味神奇的延年益寿之品,甚至有久服成仙之说。就连唐代大诗人杜甫也曾以“扫除白发黄精在,君看他年冰雪容”的佳句来赞美它。黄精味甘.性平。归脾、肺肾经.中医一般将其用于气阴两虚证候的治疗.如肺虚燥咳,证见于咳无痰、少痰、鼻燥咽干等。也用于肾虚精亏,证见腰酸腿软、头晕眼花、耳鸣、道精等。还用于脾胃虚弱,证见四肢困乏、倦怠无力、食欲不振等证的治疗。能够补脾润肺、益气养阴、生津止渴,而且味甘,性平和,身体虚弱者也容易接受,适用于脾胃虚寒、体倦乏力、精神疲倦、肺燥干咳、消渴以及阳痿等患者食用。对于糖尿病很有疗效。药理研究发现,黄精具有降血压、抑制高血糖,以及防治动脉粥样硬化与肝脂肪浸润等药理作用。据资料介绍,用黄精为主药,配以其他中药材,对治疗肺结核咯血、冠心病、心绞痛、肺燥干咳和百日咳等有显著疗效。
蜂胶是蜜蜂从植物芽孢或树干上采集的树脂,将其混入其上腭腺、蜡腺的分泌物加工而成的一种具有芳香气味的胶状固体物。是蜜蜂科动物中华蜜蜂等修补蜂巢所分泌的黄褐色或黑褐色的粘性物质,可入药。其性平,味苦、辛、微甘,有润肤生肌,消炎止痛的功效,可治疗胃溃疡、口腔溃疡、烧烫伤、皮肤裂痛,防辐射等病症。近代研究证明,蜂胶所含有的丰富而独特的生物活性物质,使其具有抗菌、消炎、止痒、抗氧化、增强免疫、降血糖、降血脂、抗肿瘤等多种功能,对人体有着广泛的医疗、保健作用,现已成为各国科学研究的热点,并成为新兴的保健品倍受推崇。
黄酮化合物包括黄酮类、黄酮醇类和双氢黄酮类等,约占蜂胶的4.13%。而且5,7-二羟基-3`,4`-二甲基黄酮和5-羟基-4`,7-二甲氧基双氢黄酮是自然界中蜂胶特有的有效成分。黄酮类化合物具有多方面的生理和药理作用,能帮助人体防治多种疾病,使机体各种功能正常化、增强化。蜂胶中的黄酮类化合物,其品种之多、含量之高超过了一般的植物药。对治疗冠心病有效的许多中草药都含有黄酮类化合物,而且具有活血化淤作用的中药,也多半含有黄酮类化合物。仅此介绍蜂胶中的两种很有特色的黄酮类化合物:
(1)槲皮素有扩张冠状血管、降低血脂、降血压、抗血小板聚集等作用。(注:血小板聚集会妨碍血液的流通,以致容易引起心脏病、脑中风等心脑血管疾病)具有止咳、祛炎、镇痛、抗病毒等作用。不仅对多种致癌物有抑制作用,而且还能抑制多种癌细胞的生长,比如已有试验表明,对卵巢癌细胞、结肠癌细胞、骨髓癌细胞、白血病细胞、乳腺癌细胞、淋巴瘤细胞的生长,都有抑制作用。换句话说,蜂胶中的槲皮素也有抗肿瘤的作用。也就是说,蜂胶中的抗癌物质就不止一种了。(注:1995年,日本林原生物化学研究所研究发现,蜂胶原料中所含的抗肿瘤成分高达5%。)
(2)芦丁(Rutin)就是芸香甙,有维生素P同样的作用。那就是,软化毛细血管、增强毛细血管的通透性,还能降低胆固醇,对防治心、脑血管硬化很有帮助。
国家权威机构检验证实:蜂胶保健品具有免疫调节功能。能明显增强巨噬细胞吞噬能力和自然杀伤细胞活性,增强抗体产量,显著增强细胞免疫功能与体液免疫功能,对胸腺、脾脏及整个免疫系统产生强有力的功能调整,增强人体抗病力与自愈力,使人不生病、少生病。
2.净化血液功能
蜂胶能使心脏收缩力增强,呼吸加深及调整血压,净化血液、调节血脂。
1975年,房柱教授发现蜂胶降血脂效应,随后开展的大规模研究与临床证实蜂胶对高血脂、高胆固醇、高血粘稠度有明显的调节作用,能预防动脉血管内胶原纤维增加和肝内胆固醇堆积,对动脉粥样硬化有防治作用,能有效清除血管内壁积存物,抗血栓形成,保护心脑血管,改善心脑血管状态及造血机能。
由于蜂胶净化血液有奇效,被称为“血管清道夫”。
乌梅别名酸梅、黄仔、合汉梅、干枝梅,为蔷薇科落叶乔木植物梅Prunus mume的近成熟果实,经烟火熏制而成。若用青梅以盐水日晒夜浸,10日后有白霜形成,叫做白霜梅,其功效类似,宜忌相同。据现代研究.青梅或梅子汁。乌梅中含钾多而含钠较少,因此,需要长期服用排钾性利尿药者宜食之;梅子中含有茶酸能促进肠蠕动,因此便秘之人宜食之。梅子中含多种有机酸,有改善肝脏机能的作用,故肝病患者宜食之。梅子中的梅酸可软化血管,推迟血管硬化,具有防老抗衰作用。
乌梅有消毒的功能,也防止食物在肠胃里腐化。
乌梅里的苹果酸把适量的水分导引到大肠,形成粪便而排出体外。
长期性的无食欲是身体里的一些器官操作得不好,胃及大肠的功能不好,生病后食欲也差了。若要康复得快,需要吃东西,能帮助恢复食欲的就是每天吃一个乌梅。
若要真正的享受长寿,就不应该受老化病的折磨。吃乌梅会刺激腮腺荷尔蒙的分泌,而这种荷尔蒙能预防老化。所以从今天开始就每天吃一个乌梅吧。
乌梅有助肾小管上皮再生,增强肾小管重吸收功能,可改善肾脏血液循环,促进肾脏功能恢复,对慢性肾炎引起的血尿、蛋白尿有效。方用乌梅炭、蝉蜕各6g,辨证加入其他中药,如玉屏风散合六味地黄汤等,每日1剂,水煎服。
栀子(学名:Gardenia jasminoides Ellis)别名:黄栀子、山栀、白蟾,是茜草科植物栀子的果实。栀子的果实是传统中药,属卫生部颁布的第1批药食两用资源,具有护肝、利胆、降压、镇静、止血、消肿等作用。在中医临床常用于治疗黄疸型肝炎、扭挫伤、高血压、糖尿病等症。
1.利胆作用 栀子及所含环烯醚萜甙等成分均有利胆作用.其醇提取物和藏红花甙、藏红花酸可使胆汁分泌量增加.其水提取物及醇提取物给家兔口服,对输胆管导出的胆汁量及固形成分无影响,但用同样制剂注射于家兔,15~30分钟胆汁分泌开始增加,持续1小时以上.给兔静脉注射藏红花素和藏红花酸钠后,胆汁分泌量增加.对栀子主要成分京尼平甙利胆机制的研究表明:京尼平甙在消化道内给药时,因水解而生成京尼平.京尼平甙在门脉内给药时不呈利胆作用,这说明京尼平甙的利胆作用是通过所生成的京尼平而生效.京尼平在显著增加胆汁流量时,能使胆汁中胆汁酸浓度下降,但对胆汁酸的排泄量基本无影响.
栀子水煎剂或冲服剂给人口服后作胆囊拍片证明服药后20及40分钟胆囊有明显的收缩作用.栀子能降低血清胆红素的含量:家兔总输胆管结扎后,口服栀子水提取液则血中胆红素减少,用药愈多,减少愈显著,醇提取液亦有相同的作用,但较水提取液作用稍弱.栀子醇提取液注射于家兔,2小时血中胆红素较对照组稍增加,6小时后较对照组低,24~48小时后明显减少,藏红花素及藏红花酸纳,亦有同样作用.在总胆管结扎的家兔,注射醇提取液,24小时末梢淋巴液中胆红素减少,藏红花素及藏红花酸纳亦有同样作用.栀子可用于胆道炎症引起的黄疸,但退黄机制比较复杂.
研究表明:栀子提取物对肝细胞无毒性作用.栀子能降低血清胆红素含量,但与葡萄糖醛酸转移酶无关.栀子亦能减轻四氯化碳引起的肝损害.
2.对胃肠道和胰腺的作用 京尼平对胃机能产生抗胆碱能性的抑制作用.京尼平十二指肠给药,对幽门结扎大鼠呈胃液分泌抑制,胃液总酸度减小,胃液pH值上升.京尼平同样剂量静脉给药,对大鼠在体胃的运动能一过性抑制其自发运动及毛果芸香碱所致的亢进运动,并能使胃张力减小,对于离体肠管,京尼平对乙酰胆碱及毛果芸香碱所致的收缩呈弱的竞争性拮抗作用.
栀子能促进胰腺分泌.京尼平甙有显著降低胰淀粉酶的作用,而其酶解产物京尼平的增加胰胆流量作用最强,持续时间较短.在胰腺炎时栀子有提高机体抗病能力、改善肝脏和胃肠系统的功能以及减轻胰腺炎等药理作用.
3.对中枢神经系统的作用 栀子醇提取物能减少小鼠自发活动,具有镇静作用,且与环己巴比妥钠有协同作用,能延长睡眠时间,尚能对抗戊四氮的惊厥.虽不能对抗士的宁的惊厥,但能减少其死亡率.有报道小鼠腹腔注射栀子醇提取物后1小时,体温平均降低3℃,大鼠腹腔注射栀子200mg/kg,体温下降可持续7小时以上.有人认为栀子镇静、降温作用的有效成分是熊果酸,其能提高戊四氮所致的小鼠半数惊厥剂量,有明显的抗惊作用.实验表明:熊果酸具有明显的中枢抑制作用.能明显降低大白鼠的正常体温;对东莨菪碱有一定的协同作用;能减少小鼠自发活动和协同阈下剂量戊巴比妥钠的睡眠;能明显对抗戊四氮引起的惊厥;但未见有明显的镇痛作用.这一实验结果提示,熊果酸与氯丙嗪有相似之处.亦有报道指出,栀子水提物、去羟栀子甙能抑制小鼠的醋酸扭体反应,故认为有镇痛作用.
4.抗病原微生物作用 栀子对金黄色葡萄球菌、脑膜炎双球菌、卡他球菌等有抑制作用,煎剂有杀死钩端螺旋体及血吸虫成虫的作用,水浸液在体外对多种皮肤真菌有抑制作用.另外,栀子乙醇提取物,水提取物,乙酸乙酯部分和京尼平甙有一定的抗炎和治疗软组织损伤的作用.其提取物制成油膏,可加速软组织的愈合.
5.对心血管系统的作用 栀子提取物能降低心肌收缩力.麻醉犬、鼠静注栀子提取物,可因心收缩容积及心输出量下降而导致血压下降.大鼠静注大剂量栀子甲醇提取物时,心电图可呈现心肌损伤和房室传导阻滞.
栀子的降血压作用部位在中枢,主要是加强了延脑副交感中枢紧张度所致.当切断两侧迷走神经后,栀子的降血压作用显著减弱或完全消失;阿托品亦可取消其降压作用.动物实验表明:栀子煎剂和醇提取物,不论何种途径给药都有降压作用,静脉给药降压迅速,维持时间亦短暂,栀子的降血压作用对肾上腺素升压作用及阻断颈动脉血流的加压反射无影响,亦无加强乙酰胆碱的作用.由于栀子的降血压作用不是因组胺释放所引起,亦与传入神经纤维无关,对神经节无阻断作用,所以给予抗组胺药如苯海拉明或静注普鲁卡因都不能改变栀子的降血压效果.
6.其他作用 栀子有一定的止血作用,生栀子的止血作用较焦栀子强.去羟栀子甙对小鼠有泻下作用.
蒲公英属菊科多年生草本植物。头状花序,种子上有白色冠毛结成的绒球,花开后随风飘到新的地方孕育新生命。蒲公英植物体中含有蒲公英醇、蒲公英素、胆碱、有机酸、菊糖等多种健康营养成分,有利尿、缓泻、退黄疸、利胆等功效。蒲公英同时含有蛋白质、脂肪、碳水化合物、微量元素及维生素等,有丰富的营养价值,可生吃、炒食、做汤,是药食兼用的植物。蒲公英的花中午开,早晨和傍晚不开放。在乡间,它也叫布谷英。
药理作用
抗病原微生物作用
蒲公英注射液在试管内对金黄色葡萄球菌耐药菌株、溶血性链球菌有较强的杀菌作用,对肺炎双球菌、脑膜炎球菌、白喉杆菌、绿脓杆菌、变形杆菌、痢疾杆菌、伤寒杆菌等及蒲公英卡他球菌亦有一定的杀菌作用.蒲公英提取液(1∶400)在试管内能抑制结核菌.蒲公英水煎剂(1∶80)能延缓ECHO11病毒细胞病变.蒲公英醇提取物31mg/kg能杀死钩端螺旋体.水浸剂对多种皮肤真菌有抑制作用.煎剂给大鼠口服,吸收良好,尿中能保持一定的抗菌作用.
保肝、利胆作用
动物实验表明:用蒲公英煎剂灌胃或用蒲公英注射液注射,对四氯化碳引起的谷丙转氨酶升高有明显抑制作用;能显著缓解四氯化碳性肝损伤引起的组织学改变.有报道指出,蒲公英在动物身上有利胆作用.蒲公英液灌胃能使胆囊收缩,奥狄括约肌松弛,有利于胆汁排入肠中.临床上对慢性胆囊痉挛及结石症有效.
抗胃溃疡作用
蒲公英煎剂给大鼠灌胃对应激性溃疡有显著保护作用;对无水乙醇所引起的大鼠胃黏膜损伤亦有显著保护作用;并能明显对抗幽门结扎大鼠胃溃疡的形成.当蒲公英与党参、川芎配伍时有协同抗胃溃疡的效果,三者构成复方抗溃疡作用更强.有报道指出,此复方抗胃溃疡与胃黏膜损伤作用的机制可能与影响胃组织内源性PGE2含量有关.
对免疫功能的作用
蒲公英煎剂在体外能显著提高人外周血淋巴细胞母细胞转化率.蒲公英多糖能显著增强艾氏癌及MM46肿瘤细胞抗原所致小鼠脚垫迟发型超敏反应强度,并有给药时间越往后越有效的特点,即于抗原刺激后的第11~20日给药或2~20隔日给药有明显作用.蒲公英多糖腹腔注射能显著增强小鼠抗体依赖性巨噬细胞的细胞毒作用.
马齿苋(学名:Portulaca oleracea L.)一年生草本,全株无毛。茎平卧或斜倚,伏地铺散,多分枝,圆柱形,长10-15厘米淡绿色或带暗红色。叶互生,有时近对生,叶片扁平,肥厚,倒卵形,似马齿状,上面暗绿色,下面淡绿色或带暗红色;叶柄粗短。花无梗,午时盛开;苞片叶状,近轮生;萼片对生,绿色,盔形,背部具龙骨状凸起,基部合生;花瓣黄色,倒卵形;雄蕊通常8,或更多,花药黄色;子房无毛,花柱比雄蕊稍长,柱头线形。蒴果卵球形;种子细小,多数,偏斜球形,黑褐色,有光泽,具小疣状凸起。花期5-8月,果期6-9月。
研究发现:马齿苋的10%醇提取液对胃黏膜损伤引起的溃疡有显著治疗作用。研究者认为:马齿苋这种新功效,可能与它富含to-3脂肪酸、维生素C等有关,这些物质具有很强的抗氧化作用并有保护胃黏膜的作用。有慢性胃炎及胃溃疡患者不妨常吃些马齿苋。
马齿苋最大的功效,是治疗大肠经的疾病。它既能解毒,又能消炎,还能祛热,对于肠道病属于热证的基本上可以通治。哪些肠道病属于热证呢?像痔疮出血、细菌性痢疾、肠道息肉、实热便秘这些都是。简单地说,大部分的肠道病都属于这个范畴,受寒引起的腹泻和脾虚引起的长期大便稀溏除外。
枳椇子:拐枣为阳性树种,生向阳山坡、山谷、沟边及路旁或栽培;主要分布陕西、江西、安徽、浙江、广东、福建、湖北、湖南、广西、河南、四川、贵州、云南等省。万寿果树是稀有树种,为木本植物,树高五至十几米不等,果树每年入春开花,10月果实成熟,果实形态酷似楷书“万”子,故称之树为万寿果树,果则为万寿果,果实熟透可生吃,果肉多浆,无果核,种子裸露在果肉之外,味浆甜略有甘涩,亦可做汤,汤味独特醇香。果实有益气补血功效,老少皆宜。
拐枣具有医用价值,可治疗多种疾病。其果梗、果实、种子、叶及根等均可入药,中药称其果实为枳椇子。其药用最早见于《唐本草》。李时珍《本草纲目》说它″味甘、性平、无毒,有止渴除烦,去膈上热,润五脏,利大小便,功同蜂蜜″,是糖尿病患者的理想果品。″其枝、叶,止呕逆,解酒毒,辟虫毒″。拐枣果梗酿制的″拐枣白酒″,性热,有活血、散瘀、去湿、平喘等功效。民间常用拐枣酒泡药或直接用于医治风湿麻木和跌打损伤等症。特别是对地下、井下、水下、潮湿环境下从事工作和劳动的人,更具有保健作用。在中医上,其种子、木质入药,有清热、利尿、解酒毒之功效。古书中对其解酒毒,有很多趣闻记载。陆玑《疏义》云:″……昔有南人修舍用此木,误落一片入酒瓮中,酒化为水也″。元代《本草衍义补遗》中记有:″一男子年三十余,因饮酒发热,又兼房劳虚乏。乃服补气血之药,加葛根以解酒毒。微汗出,人反懈怠,热如故。此乃气血虚,不禁葛根之散也。必须鸡距子解其毒,遂煎药中加而服之,乃愈″。《本草纲目》中也记有:″枳椇,《本草》只言木能败酒,而丹溪朱氏治酒病往往用其实,其功当亦同也。按《苏东坡集》云:眉山揭颍臣病消渴,日饮水数斗,饭亦倍常,小便频数。服消渴药愈年,疾日甚,自度必死。予令延蜀医张肱诊之。笑曰:君几误死。乃取麝香当门子以酒濡湿,作十许丸,用棘枸子(枳椇子)煎汤服之,遂愈。问其故。肱曰:消渴消中皆脾弱肾败,土不制水而成疾。今颖臣脾脉极热而肾气不衰,当由果实、酒物过度,积热在脾,所以食多而饮水。水饭既多,溺不得不多,非消非渴也。麝香能解酒果花木毒。棘枸亦胜酒,屋外有此木,屋内酿酒多不佳。故此二物为药,以去其酒果之毒也″。其木汁入药,可治狐臭。《本草纲目》载有一例云:″用橘枸树(即拐枣)凿孔,取汁一二碗,用青木香、东桃、西柳、七姓妇人乳,一处煎一二沸。就热,于五月五日鸡叫时洗了,将水放在十字路口,速回勿顾,即愈″。此说带有迷信色彩,可能有些玄虚。
决明子是“决明”的种子,为常用中药,种子入药,具有清肝明目、通便的功能。主治高血压、头痛、眩晕、急性结膜炎、角膜溃疡、青光眼、痈疖疮疡等症。用其叶泡茶,中老年人长期饮用,可使血压正常,大便通畅。决明在植物群落里生命力极其旺盛,常常与其他植物争夺营养,因此在北美洲等地区,决明被视为一种难以根除的野草。
《本草正义》:决明子明目,乃滋益肝肾,以镇潜补阴为义,是培本之正治,非如温辛散风,寒凉降热之止为标病立法者可比,最为有利无弊。决明子热水提取物口服670mg/kg对四氯化碳中毒小鼠肝脏有弱的解毒作用。决明子经石油醚脱脂、氯仿提取,再用甲醇提取,结果该甲醇提取物有显著的护肝作用。进一步从中分得大黄酚-1-O-三葡萄糖甙、大黄酚-1-O-四葡萄糖甙在1mg/ml时对四氯化碳损伤的肝细胞有弱的保护作用,还发现芦荟大黄素也有类似的抗肝毒作用。
黑芝麻为胡麻科脂麻的黑色种子,含有大量的脂肪和蛋白质,还有糖类、维生素A、维生素E、卵磷脂、钙、铁、铬等营养成分。可以做成各种美味的食品。一般人均可食用。
黑芝麻含有的多种人体必需氨基酸,在维生素E和维生素B1的作用参与下,能加速人体的代谢功能;黑芝麻含有的铁和维生素E是预防贫血、活化脑细胞、消除血管胆固醇的重要成分;黑芝麻含有的脂肪大多为不饱和脂肪酸,有延年益寿的作用。
中医中药理论认为,黑芝麻具有补肝肾、润五脏、益气力、长肌肉、填脑髓的作用,可用于治疗肝肾精血不足所致的眩晕、须发早白、脱发、腰膝酸软、四肢乏力、步履艰难、五脏虚损、皮燥发枯、肠燥便秘等病症,在乌发养颜方面的功效,更是有口皆碑。
一般素食者应多吃黑芝麻,而脑力工作者更应多吃黑芝麻。黑芝麻所含有的卵磷脂是胆汁中的成分之一,如果胆汁中的胆固醇过高及与胆汁中的胆酸、卵磷脂的比例失调,均会沉积而形成胆结石,卵磷脂可以分解、降低胆固醇,所以卵磷脂可以防止胆结石的形成。现代医学研究结果证实,凡胆结石患者,其胆汁中的卵磷脂含量一定不足,常吃黑芝麻可以帮助人们预防和治疗胆结石,同时还有健脑益智、延年益寿的作用。确实是中老年人常用的保健佳品。
适宜肝肾不足所致的眩晕、眼花、视物不清、腰酸腿软、耳鸣耳聋、发枯发落、头发早白之人食用;适宜妇女产后乳汁缺乏者食用;适宜身体虚弱、贫血、高脂血症、高血压病、老年哮喘、肺结核,以及荨麻疹,习惯性便秘者食用;适宜糖尿病、血小板减少性紫癜、慢性神经炎、末梢神经麻痹、痔疮以及出血性素质者食用。
黑豆为豆科植物大豆(学名:Glycinemax(L.)merr)的黑色种子。又名橹豆、黑大豆等,味甘性平。黑豆具有高蛋白、低热量的特性,外皮黑,里面黄色或绿色。
营养分析:
1.黑豆营养全面,含有丰富的蛋白质、维生素、矿物质,有活血、利水、祛风、解毒之功效。
2.黑豆中微量元素如锌、铜、镁、钼、硒、氟等的含量都很高,而这些微量元素对延缓人体衰老、降低血液粘稠度等非常重要。
3.黑豆皮为黑色,含有花青素,花青素是很好的抗氧化剂来源,能清除体内自由基,尤其是在胃的酸性环境下,抗氧化效果好,养颜美容,增加肠胃蠕动。
谷芽,中药名。为禾本科植物稻(学名:Oryza sativa L.)或同科植物粟(学名:Setaria italica(L.)Beauv.)的成熟果实经发芽干燥而成。全国多数地方均可生产,主产南方各省区。将稻谷用水浸泡后,保持适宜的温、湿度,待须根长至约1cm时,干燥。生用或炒用。花、果期6-10月。稻芽、麦芽均具消食和中,健胃之功,主治米面薯芋类食滞证及脾虚食少等。但麦芽消食健胃力较强;而稻芽力较弱,故稻芽更宜于轻证,或病后脾虚者。但二药临床常相须为用。《本草经疏》:蘖米即稻蘖也。具生化之性,故为消食健脾、开胃和中之要药,脾胃和则中自瘟,气自下,热自除也。
山楂,可食用植物,仁果类水果,质硬,果肉薄,味微酸涩。落叶灌木。枝密生,有细刺,幼枝有柔毛。小枝紫褐色,老枝灰褐色。能防治心血管疾病。山楂是我国特有的药果兼用树种。
山楂味酸性温,气血并走,化瘀而不伤新血,行滞气而不伤正气,应用于肉食积滞证,泻痢腹痛、疝气痛、瘀滞腹痛胸痛、恶露不尽、痛经、吐血、便血等。现代单用本品制剂治疗心血管疾病、细菌性痢疾等,均有较好疗效。山楂含有大量的维生素C与微量元素,能够扩张血管,降低血压,降低血糖,能够改善和促进胆固醇排泄而降低血脂,预防高血脂的发生,山楂能够开胃促进消化,山楂所含有的脂肪酶也能够促进脂肪的消化。山楂所含有的黄酮类与维生素c、胡萝卜素等物质能够阻断并减少自由基的生成,可增强机体的免疫力,延缓衰老,防癌抗癌。山楂能够活血化瘀,帮助消除瘀血状态,辅助治疗跌打损伤。山楂对子宫有收缩作用,在孕妇临产时有催生效果。山楂主要含有黄酮类、低聚黄烷类、有机酸类、微量元素,另外还有含有三萜类、甾体类和有机胺类等成分。近几年来,山楂在降血脂、降血压、抗脑血及其作用机制方面取得了重大进展。山楂可单味应用,亦可与神曲、麦芽、莱菔子等配伍,加强消食化积之功。其含维生素C、维生素B、胡萝卜素及多种有机酸,口服能增加胃中消化酶的分泌,所含蛋白酶、脂肪酸,可促进肉食分解消化。
葛根,中药名。为豆科植物野葛的干燥根,习称野葛。秋、冬二季采挖,趁鲜切成厚片或小块;干燥。甘、辛,凉。有解肌退热,透疹,生津止渴,升阳止泻之功。常用于表证发热,项背强痛,麻疹不透,热病口渴,阴虚消渴,热泻热痢,脾虚泄泻。
明朝著名的医学家李时珍对葛根进行了系统的研究,认为葛根的茎、叶、花、果、根均可入药。他在《本草纲目》中这样记载:“葛,性甘、辛、平、无毒,主治:消渴、身大热、呕吐、诸弊,起阴气,解诸毒”。
作用功效:
1.提高肝细胞的再生能力,恢复正常肝脏机能,促进胆汁分泌,防止脂肪在肝脏堆积。
2.促进新陈代谢,加强肝脏解毒功能,防止酒精对肝脏的损伤。
3.对高血脂形成的冠状动脉硬化,通过改善心肌缺血状态,防治冠心病、心绞痛、心肌梗塞等心血管疾病。
4.对高血脂形成的脑动脉硬化,通过改善脑缺血状态,防治脑梗塞、偏瘫、血管性痴呆等脑血管疾病。
5.强化肝胆细胞自身免疫功能,抵抗病毒入侵。
6.降血糖,具有延缓衰老、调节血脂血糖、促进造血功能等方面的作用,并应用于临床。
适用人群:
1.成年男子,经常饮酒,抽烟的人士、酒精代谢中毒者
2.预防肝炎,提高肝脏解毒功能,修复肝损细胞的人群
3.高血压、高血脂、高血糖及偏头痛等心脑血管病患者
4.更年期妇女、易上火人群、常用烟酒者
5.女性滋容养颜,中老年人日常饮食调理等
6.预防黑斑、青春痘、肝斑的人群
7.改善微循环促进尿酸结晶溶解,提高肾血流量,促进多排尿酸。
薄荷属(学名:Mentha),爲唇形科的一属,包含25个种,其中胡椒薄荷(Peppermint)及绿薄荷(Spearmint)为最常用的品种,而植物的不同来源使薄荷有六百多种品名。最早期于欧洲地中海地区及西亚洲一带盛产。现时主要产地为美国、西班牙、意大利、法国、英国、巴尔干半岛等,亚洲也有一些地方种植,而中国大部分地方如江苏、浙江、江西等都有出产。
1、抗病毒作用:薄荷水煎剂1∶20浓度,对病毒ECHO11株有抑制作用。
2、镇痛、止痒作用:薄荷脑主要作外用止痒、微弱的局麻及对抗刺激剂,涂于局部由于刺激神经而引起凉感,并抑制痛觉神经。
3、抗刺激、止咳作用:薄荷脑的抗刺激作用导致气管产生新的分泌,而使稠厚的粘液易于排出,故有祛痰作用,亦有报道薄荷脑对豚鼠及人均有良好的止咳作用。
4、杀菌作用:薄荷脑有很强的杀菌作用,d-薄荷脑比1-薄荷脑的抑菌作用强。
5、抗着床、抗早孕作用:薄荷油对小白鼠具有一定的抗着床与抗早孕作用,作用强度随剂量增加,腹腔注射0.035ml/只,抗着床率达100%。终止妊娠的原因可能是子宫收缩加强,也不能排除蜕膜组织等的直接损伤。宫内给药,薄荷油不仅可使原孕第6天所见的胚珠坏死,而且可使之排出体外。
6.利胆作用:薄荷的丙酮干浸膏和50%甲醇干浸膏均具有利胆作用,与对照组相比,胆汁分泌量均有明显的增加。含有挥发油多的丙酮干浸膏组的利胆效果比50%甲醇干浸膏组强。实验证明,除挥发油中主要成分薄荷醇具有很强的利胆作用外,薄荷油中还含有其他利胆作用成分。此外,把薄荷醇的醇羟基乙酰化后,其利胆作用也减弱了,说明醇羟基在利胆作用的产生上起着重要的作用。
佛手(学名:Citrus medica L.var.sarcodactylis Swingle):果实在成熟时各心皮分离,形成细长弯曲的果瓣,状如手指,故名佛手。
常绿灌木或小乔木,高达丈余,茎叶基有长约6厘米的硬锐刺,新枝三棱形。单叶互生,长椭圆形,有透明油点。花多在叶腋间生出,常数朵成束,其中雄花较多,部分为两性花,花冠五瓣,白色微带紫晕,春分至清明第一次开花,常多雄花,结的果较小,另一次在立夏前后,9-10月成熟,果大供药用,皮鲜黄色,皱而有光泽,顶端分歧,常张开如手指状,故名佛手,肉白,无种子。
通常用作中药,或因其果形奇特,而作为观赏植物。佛手柑被大量制作成凉果食用及出售
1、平喘、祛痰作用:本品所含的柠檬内酯对组胺所致豚鼠离体气管收缩,有对抗作用;在蛋清致敏的豚鼠离体回肠和离体气管试验表明有一定抗过敏活性。麻醉猫肺溢流试验静脉注射柠檬内酯5-10mg/kg有一定的抗组胺作用。
2、对胃、肠道平滑肌的作用:本品醇提物对大鼠、兔离体肠管有明显抑制作用,静脉注射给药对麻醉猫、兔在体肠管亦有同样抑制作用。对乙酰胆碱引起的兔十二指肠痉挛有显著解痉作用,而对氯化钡引起的则不能完全对抗。醇提物2.25g/kg静脉注射,能迅速缓解氨甲酰胆碱所致的麻醉猫胃、肠和胆囊的张力增加。
3、对中枢的抑制作用:小鼠1p佛手醇提物20g/kg,自发活动明显减少并可维持2h。同剂量还可显著延长小鼠戊巴比妥钠睡眠时间,并能延长小鼠士的宁惊厥的致死时间和戊四氮或咖啡因引起的惊厥发生时间与致死时间,且能降低其死亡率。
4、对心血管系统的作用:佛手醇提物能显著增加豚鼠离体心脏的冠脉流量和提高小鼠的耐缺氧能力;对大鼠因垂体后叶素引起的心肌缺血有保护作用,并使豚鼠因结扎冠状动脉引起的心电图变化有所改善,对氯仿一肾上腺素引起的心律失常也有预防作用。
5、抗炎、抗病毒作用:本品所含橙皮甙对豚鼠因缺乏维生素C而致的眼睛球结膜血管内血细胞凝聚及毛细血管抵抗力降低有改善作用;它与栓塞(Thrombogenic)饲料或与致粥样硬化饲料共同喂养大鼠,均可延长大鼠存活时间。能刺激缺乏维生素C豚鼠的生长速度。在加入小泡性口炎病毒前,将小鼠纤维细胞成于200?g/mL的橙皮甙中预先孵化,叮保护细胞不受病毒侵害约24h。用橙皮甙预先处理Hela细胞,能顶防流感病毒的感染。橙皮甙的抗病毒活性能被透明质酸酶所消除。本品所含的地奥明具有维生素P样作用,能降低兔毛细血管渗透性作用,有维生素C2样作用。能增强豚鼠毛细血管的抵抗力和减少肾上腺维生素C的排出。地奥明还有抗炎作用,对角叉菜胶引起的大鼠足跖水肿有消肿作用,腹腔注射的ED50为100mg/kg。
6、其他作用:本品所含的香柑内酯对皮肤有光学活性,作用仅次于8-甲氧基补骨脂素。有杀软体动物作用,主要用于杀灭钉螺。有一定对抗肝素的抗凝血和止血作用。对兔有一过性降血压作用。还有抗微生物活性。橙皮甙有预防冻伤和抑制大鼠眼晶状体的醛还原酶作用。
芡实属中药中的收涩药,为睡莲科植物芡的干燥成熟种仁,产于湖北、湖南、江西、安徽等地,又名水流黄、鸡头果、苏黄等。功能补中益气,益肾固精,除湿止带。用于梦遗滑精,遗尿尿频,脾虚久泻,白浊,带下。同时具有很高的食疗价值,在我国自古作为永葆青春活力、防止未老先衰之良物。
秋凉后如马上食入大量难以消化的补品,势必加重脾胃的负担,甚至损害消化功能。因此此时进补的原则是既要营养滋补,又要容易消化吸收。芡实就具有这一特点,中医认为,“其性平,味甘、涩。有补脾止泻、益肾固精、祛湿止带的功能。用于梦遗滑精,遗尿尿频,脾虚久泻,白浊,带下等症。”其含碳水化合物极为丰富,含脂肪很少,因而极容易被人体吸收。并且人体经过服用芡实调整之后,再服用其他补品消化系统就能适应了。
芡实被誉为“水中人参”,有健脾养胃,益肾固精的作用。并有南芡、北芡之分。南芡主要产于湖南、广东、皖南以及苏南一带地区。北芡又称池芡,主产于山东、皖北及苏北一带,质地略次于南芡。中医养生学认为,芡实抗衰延年,最益脾胃,宋代大文豪苏东坡到老年仍然身健体壮,面色红润,才思敏捷。原来据他在书中自述,主要得益于数十年如一日地坚持天天食用煮熟的芡实,所以才腰腿壮健,行走有力。提倡在秋天进食芡实,它的意义还在于可调整被炎夏所消耗的脾胃功能,脾胃充实以后,再吃较多的补品或难消化的补药,人体就能适应了,对身体也就有益无碍了。
莲子为小坚果。呈椭圆形、卵形或卵圆形,其大小因品种而异,一般长1.6-1.8厘米,宽1.1-1.2厘米,千粒重1100-1400克,幼果期果皮绿色,革质,后由绿转褐色,成熟时呈棕褐色、灰褐色和黑褐色。有细纵纹和较宽的脉纹。一端中心呈乳头状突起,深棕色,多有裂口,其周边略下陷。质硬。种皮薄,不易剥离。子叶2,黄白色,肥厚,中有空隙,具绿色莲子心。无臭,味甘、微涩。
古人说,吃莲子能返老还童、长生不老。这一点固不可信,但关于其在养心安神、健脑益智、消除疲劳等方面的药用价值,历代医药典籍多有记载。比如在《神农本草》、《本草拾遗》、《本草纲目》、《本草备要》中都有据可查。现代药理研究也证实,莲子有镇静、强心、抗衰老等多种作用。莲子营养十分丰富,除含有大量淀粉外,还含有β-谷甾醇,生物碱及丰富的钙、磷、铁等矿物质和维生素。每100克莲子含钙89毫克,含磷量可达285毫克,钾元素虽然不足2.1毫克,但在所有动、植物食品中却位居榜首。
杭白菊,又名甘菊、白菊花、茶菊、药菊。湖州练菊花,具有花瓣洁白如玉,花蕊黄如纯金的特点。是甘菊中的佳品。杭白菊有很高的药用价值,还有延年益寿的功效,《补农书》载:“甘菊性甘温,久服最有益。”元代《本草衍义补遗》说:“菊花能补阴”。李时珍《本草纲目》道:菊能利五脉,调四肢,治头风热补;还记载一段神话:“神仙传言,康风子、朱孺之皆以服菊成仙”。可见杭白菊的功效。练市杭白菊,还可代茶饮用,其色香味不亚于龙井茶。经常饮用,能增强毛细血管抵抗力,抑制毛细血管的通性,起到抗炎强身的作用。
经祖国中医和西医学的共同研究表明,杭白菊泡茶饮用,具有以下功效:
1.对中枢神经有镇静作用;
2.有解热作用;
3.增强毛细血管抵抗力、扩张冠状动脉作用;
4.有抑菌作用,菊花水煎剂及水浸剂对金黄色葡萄球菌、痢疾杆菌、变形杆菌、伤寒杆菌、副伤寒杆菌、霍乱弧菌、乙型溶血链球菌、大肠杆菌、绿脓杆菌、人型结核杆菌及流感病毒(PR3株)均有抑制作用。
杭白菊的元素含量:杭白菊中含锌,钠,铁等元素,尤其是铁的含量最高。铁是细胞中的重要组成成分,三羧酸循环中有一半以上的酶均含有铁,或需要铁作为辅助因子。铁和人体免疫防御功能有密切的关系,它可协调锌,钙,镁的体内代谢。杭白菊的镍,锌,铁的含量较多,而对于钠和钙,野菊花要比杭白菊高,差别最大的是,杭白菊中的铅含量是野菊的6倍之多,这与它们所生长的生态环境有关,也给我们人类敲响了环境铅污染的危害性。由于杭白菊含有较低的铅,含有较高矿物质,因此具有较高的医疗及保键价值。
厚朴花为一味中药名,来源于木兰科植物厚朴或凹叶厚朴的干燥花蕾。春季花未开放时采摘,稍蒸后,晒干或低温干燥。性微温,味苦,具有主治理气,化湿的药用价值。味苦,性微温,气香。归脾、胃经。主治理气,化湿。用于胸脘痞闷胀满,纳谷不香。用量为3~9克。阴虚液燥者忌用。
绿萼梅:舒肝,和胃,化痰。治梅核气,肝胃气痛,食欲不振,头晕,瘰疬。绿萼梅花色洁白,香味极浓,有″花中君子″的美称。它性平,最大特点就是能够理气,调理脾胃,疏理气血,但却不会伤阴,非常难得。所以无论是家里的老人,还是幼小宝宝,都可以用绿萼梅来保健。常用于郁闷心烦、肝胃气痛、食欲不振等症。绿萼梅水外用还能预防面部血瘀形成斑点。
药物应用
1.肝胃气痛。本品芳香行气入肝胃,能疏肝解郁,醒脾,理气和中。治疗肝胃气滞之胁肋胀痛,脘腹痞满,嗳气纳呆等,可与柴胡、佛手、香附等配伍。
2.梅核气。本品芳香行气,化痰散结。治疗痰气郁结之梅核气,可与半夏、厚朴、茯苓等同用。
玳玳花,别名回青橙、枳壳花、酸橙花,拉丁文名Citrus aurantium常绿灌木,枝楞、细长,叶互生,革质,椭圆形,春夏(4~5)月开白花,香气浓郁,果实扁球形,当年冬季为橙红色,翌年夏季又变青,故称:″回青橙″,因有果实数代同生一树习性,亦称″公孙桔″。玳玳花是香科常绿灌木,头一年的果实留在树上过冬,次年开花结新果,陈果皮色由黄回青,两代果实同一棵树上,所以叫玳玳。玳玳花略微有点苦,但香气浓郁,闻之令人忘倦。
玳玳花全草都含有强心甙和非强心甙的多种成分,见于许多国家的药典之中。
中医称之为福寿草。它具有强心、利尿、镇静及减慢心率的功能,能降低神经系统的兴奋性和脊髓反射机能亢进,用于急性病和慢性心功能不全。主治充血性心力衰竭、心脏性水肿和心房纤维性颤动,与溴化银的合用能加强对癫痫病的治疗作用。
功能主治行气宽中,消食,化痰。用于胸腹闷胀痛、食积不化、痰饮、脱肛、疏肝,和胃,理气。治胸中痞闷,脘腹胀痛,呕吐、少食。
佛手花为芸香科植物佛手CitrusmedicaL.var.sarcodactylis(Noot.)Swingle的花朵和花蕾。佛手又名九爪木、五指橘、佛手柑。为芸香科常绿小乔木。主产于闽、粤、川、江浙等省的佛手,其中浙江金华佛手最为著名,被称为“果中之仙品,世上之奇卉”,雅称“金佛手”。佛手不仅有较高的观赏价值,而且具有珍贵的药用价值、经济价值。佛手全身都是宝,其根、茎、叶、花、果均可入药,辛、苦、甘、温、无毒,入肝、脾、胃三经,有理气化痰,止咳消胀、舒肝健脾和胃等多种药用功能。据史料记载,佛手的根可治男人下消、四肢酸软;花、果可泡茶,有消气作用;果可治胃病、呕吐、噎嗝、高血压、气管炎、哮喘等病症。据《归经》等载,佛手并具治鼓胀发肿病,妇女白带病及醒酒作用,是配制佛手中成药的主要原料。
功效:疏肝理气;和胃快隔
考证:出自《随息居饮食谱》。科属分类:芸香科
主治:肝胃气痛;食欲不振
生态环境:生于热带、亚热带。
各家论述:《药材资料汇编》:平肝胃气痛。
薏苡(学名:Coix lacryma-jobi L.)为禾本科,一年生粗壮草本,须根黄白色,海绵质,直径约3毫米。花果期6-12月。《本经疏证》:论者谓益气、除湿、和中,健脾,薏苡与术略似,而不知毫厘之差,千里之谬也。盖以云乎气,则术温而薏苡微寒,以云乎味,则术甘辛而薏苡甘淡。且术气味俱厚,薏苡气味俱薄,为迥不相侔也。此其义盖见于《金匮要略·痉湿蝎篇》,曰湿家身烦疼,当与麻黄加术汤,发其汗为家,慎勿以火攻之。曰病者一身尽疼,发热日晡所剧者,此名风湿,此病伤于汗出当风,或久伤取冷所致也,可与麻黄杏仁薏苡甘草汤。夫身烦疼者,湿而兼寒;一身尽疼者,湿而兼风。寒从阴化,风从阳化。故身烦疼者,属太阳;发热日晡所剧者,属阳明。属太阳者宜发汗,属阳明者宜清热,发汗所以泄阳邪,清热所以折阳邪,质之以用术用桂者为发汗,薏苡则为清热矣。虽然,薏苡既治风湿,又主筋急铁拘挛,不能屈伸,彼风湿相搏,骨节疼烦,不得屈伸,风湿相搏,身体疼烦,不能自转侧,独不用薏苡何耶?
薏苡仁还是一味美容价值较高的药用食品。临床实验证实,薏苡仁具有一定的抑菌、抗病毒功效。用它来治疗扁平疣有70.8%的有效率;治疗寻常性赘疣也有30.6%的有效率。用法是每日取100克薏苡仁,煮粥或煮汤食用即可。最初几天,疣区会增大变红,继续服用一个多月后,疣便会逐渐干燥脱屑,以致消退。长期服用,可以使皮肤光滑细腻、白净有光泽。
扁豆世界各热带、亚热带地区均有栽培,扁豆花有红白两种,豆荚有绿白、浅绿、粉红或紫红等色。嫩荚作蔬食,白花和白色种子入药,有利于暑湿邪气的祛除,健脾止泻之效,同时扁豆还有显著的消退肿瘤的作用。
线叶金雀花,又名南非茶或者南非博士茶。是南非西开普敦Cedarberg等地区生长的的一种草本针状灌木,加工后制成的一种天然健康饮品,含丰富的抗氧化类黄酮,对清除人体自由基,调节人体机能,预防和控制多种疾病起显著的疗效。
杜仲是雌雄双株的树,雄花就是杜仲雄树开的花。杜仲,又名思仙(《本经》)。地球上只有一属一种,在第四纪冰期来临时,便在欧洲和亚州部分地区消失,只在亚州中国的中部地区存活至今,故有“植物活化石”的美称,常醉酒的人都知道,人酒醉以后第二天是最难受的,常常头痛、胸涨,又烦又闷有一种说不出的痛苦。
杜仲雄花茶中含有的环烯醚萜类和苯丙素类等活性成分,能够有效分解酒精,降低烟、酒精对人体的危害,醒酒作用尤为突出,醉酒后或第二天喝上浓浓的一杯,就可感觉是神清气爽,醉意大减,而且对于肝脏也有很好保护作用,是老板、白领等饮酒聚会后的最佳饮品。
显齿蛇葡萄叶源于葡萄科蛇葡萄属显齿蛇葡萄。有效成分二氢杨梅素具有抗氧自由基的作用,能抑制体内血栓的形成,对降血脂等有独特效果。显齿蛇葡萄含有丰富的黄酮类物质二氢杨梅素,具有明显的保肝护肝作用,抑制脂肪肝的形成。研究发现蛇葡萄中的扬梅树皮素能明显降低四氯化碳、D-半乳糖胺和异硫氰酸萘酯致小鼠急性肝损伤模型血清中ALT、AST活性和T-BIL含量,减轻肝组织的变性和坏死,从而达到保肝降酶退黄的作用。
裸藻是古代原生动物眼虫的植物学名称,因为眼虫同时具有动物与植物两种特性,它是一种″原生动物″,但是同时,眼虫的细胞却又有含叶绿素的叶绿体,能够进行光合作用,自己制造营养。因此,植物学家认为,它是一种″原生植物″;由于它的细胞外面没有细胞壁,植物学家给它起了另外一个名字--裸藻。
橙者儿裸藻素同时具备了植物与动物两种特征的微细胞藻类。无细胞壁且均衡地含有59种人体必需的营养元素,能够全面地补充人体所需的营养,缓解隐性饥饿,是比较高效的天然膳食营养补充剂。其含有的裸藻多糖成分,能清除有害胆固醇、中性脂肪、重金属等多余物质的同时促进体内有益酶的活性,调整肠胃、保护肝脏、净化血液,对过敏性皮炎亦有缓和作用,应用于便秘、宿便、癌症、艾滋病等及防治过敏症状的药物中。
丹凤牡丹花分为三部分:花瓣、花蕊、花粉。牡丹花瓣挥发油已鉴定出49种成分,主要是含有天然香味物质,如香茅醇、香叶醇、芳樟醇等具有软化血管、养神静心等重要作用;同时还含有丰富的萜烯及烃类化合物、花青素、黄酮类化合物、活性多糖等重要物质。花蕊则含有大量游离氨基酸、多糖,尤其是烟酸含量极高。油用牡丹花粉总蛋白含量39%,是所有花粉中含量最高的,此外还含有黄酮类化合物、多糖及激素类物质。
青钱柳(拉丁名:Cyclocarya paliurus(Batal.)Iljin.[Pterocarya paliurusBatal.;P.micropaliurus T soong],Folium Cylocaryae Paliuri)的叶,青钱柳又摇钱树、麻柳,胡桃科,属于国家二级保护树种,我国南方多省均有发现,多以零星分布。乃冰川四纪幸存下来的珍稀树种,仅存于中国。
青钱柳叶具有健脾化湿、清热通腑、疏肝理气、滋阴补肾的作用,对因脾运不健、痰浊、嗜食肥甘厚味、懒动、腹满积食、肝淤气滞而致的肥胖,有良好的改善。
青钱柳叶具清热消渴解毒之效。现代科学实验发现青钱柳叶含多糖,三萜,皂苷,黄酮等多种重要药效成分,同时还检出氨基酸,维生素,锗,硒,铬,钒,锌,铁,钙等多种珍贵的微量元素。能增强人体免疫力,抗氧化,抗衰老,适宜现代三高类慢性疾病人群饮用。有效降低甘油三脂和胆固醇,具有神奇的天然降血压、降血糖、降血脂的功能,同时对增强人体免疫力、抗氧化、抗衰老,保肝脂肪肝具有独特作用尤其对糖尿病人群,有显著降血糖的功效。
辣木叶指原产于印度的多年生热带落叶乔木辣木树(又称为鼓槌树)的树叶,可食用。辣木叶粉有降血糖、降脂、降压、抗肿瘤、抗氧化、通便、利尿、驱虫、改善睡眠等功效,长期食用可增强人体免疫功能,延缓衰老、预防疾病。印度草医学认为辣木可预防300种疾病。特别是近几年辣木受到欧美等发达国家很多研究机构和消费者的关注和热捧。
本发明具有如下优点:本发明的全营养配方食品食品,以富硒植物蛋白粉、黑芝麻和黑豆为主要营养成分,加入多种保肝护肝功能常用的中草药;加入低聚甘露糖有助于肠道吸收,对肠道吸收功能不好的中老年人群效果显著。本发明按常规方法制成粉剂长期服用,易于吸收。
除了上面所描述的目的、特征和优点之外,本发明还有其它的目的、特征和优点。下面将对本发明作进一步详细的说明。
具体实施方式
以下对本发明的实施例进行详细说明,但是本发明可以根据权利要求限定和覆盖的多种不同方式实施。
实施例1
一种适用于肝病患者的全营养配方食品,包括以下重量百分比的成分:石斛0.8%、山楂0.3%、灵芝1.5%、制黄精0.15%、木瓜0.35%、蜂胶0.2%、蒲公英0.7%、马齿苋1.2%、枳椇子2.5%、蛹虫草0.7%、决明子1.5%、黑芝麻12%、黑豆16%、谷芽2.8%、薄荷1.5%、芡实0.7%、莲子1.5%、麦芽0.8%、栀子1.4%、杭白菊1.6%、厚朴花2.2%、佛手0.8%、、绿梅花1.5%、乌梅0.8%、玳玳花0.6%、佛手花0.4%、薏苡仁1.3%、扁豆1.5%、线叶金雀花1.6%、杜仲雄花1.3%、青钱柳叶0.4%、显齿蛇葡萄叶0.5%、裸藻0.3%、丹凤牡丹花0.2%、辣木叶2.4%、富硒植物蛋白粉35%和低聚甘露糖余量。
所述的富硒植物蛋白粉的硒含量是45mg/kg。
实施例2
一种适用于肝病患者的全营养配方食品,包括以下重量百分比的成分:石斛0.5%、山楂0.5%、灵芝1%、制黄精0.2%、木瓜0.2%、蜂胶0.3%、蒲公英0.5%、马齿苋2%、枳椇子2%、蛹虫草0.8%、决明子1%、黑芝麻15%、黑豆10%、谷芽3%、薄荷1%、芡实1%、莲子2%、麦芽0.5%、栀子2%、杭白菊1%、厚朴花3%、佛手0.5%、绿梅花1%、乌梅1%、玳玳花0.5%、佛手花0.5%、薏苡仁1%、扁豆2%、线叶金雀花1%、杜仲雄花1.5%、青钱柳叶0.5%、显齿蛇葡萄叶0.3%、裸藻0.4%、丹凤牡丹花0.1%、辣木叶2%、富硒植物蛋白粉40%和低聚甘露糖余量。
所述的富硒植物蛋白粉的硒含量是60mg/kg。
实施例3
一种适用于肝病患者的全营养配方食品,包括以下重量百分比的成分:石斛1%、山楂0.2%、灵芝2%、制黄精0.1%、木瓜0.5%、蜂胶0.1%、蒲公英1%、马齿苋1%、枳椇子3%、蛹虫草0.5%、决明子2%、黑芝麻15%、黑豆20%、谷芽2%、薄荷2%、芡实0.5%、莲子1%、麦芽1%、栀子1%、杭白菊2%、厚朴花2%、佛手1%、绿梅花2%、乌梅0.5%、玳玳花0.8%、佛手花0.2%、薏苡仁2%、扁豆1%、线叶金雀花2%、杜仲雄花1%、青钱柳叶0.2%、显齿蛇葡萄叶0.8%、裸藻0.2%、丹凤牡丹花0.3%、辣木叶3%、富硒植物蛋白粉30%和低聚甘露糖余量。
所述的富硒植物蛋白粉的硒含量是35mg/kg。
实施例4
适用于肝病患者的全营养配方食品,包括以下重量百分比的成分:石斛0.5%、山楂0.2%、灵芝1%、制黄精0.1%、木瓜0.2%、蜂胶0.1%、蒲公英0.5%、马齿苋1%、枳椇子2%、蛹虫草0.5%、决明子1%、黑芝麻8%、黑豆10%、谷芽2%、薄荷1%、芡实0.5%、莲子1%、麦芽0.5%、栀子2%、杭白菊1%、厚朴花2%、佛手0.5%、绿梅花1%、乌梅0.5%、玳玳花0.5%、佛手花0.2%、薏苡仁1%、扁豆1%、线叶金雀花1%、杜仲雄花1%、青钱柳叶0.2%、显齿蛇葡萄叶0.7%、裸藻0.3%、丹凤牡丹花0.25%、辣木叶2%、富硒植物蛋白粉50%和低聚甘露糖余量。
以下对实施例1-4制作的适用于肝病患者的全营养配方食品进行临床效果实验。
实验1
实验征集到肝病患者共计250人,年龄从40-60周岁,男女不限,每个实施例和对照例有50人参加实验。
实验方法:每组患者服用实施例1-4的全营养配方食品粉剂,每日3次,每次20g,服用方法:三餐半小时后100ml温开水冲调服用,实验期间不服用任何药物,90天以后统计疗效,对照例50人不服用任何药物,仅服用黑芝麻、黑豆和富硒植物蛋白粉混合粉剂。
有效:患者的肝病症状显著改善;
无效:患者的肝病症状无明显改善。
实验结果见表1:
表1:配方食品对肝病患者的治疗结果
由以上测试结果可以知道,长期服用本发明的适用于肝病患者的全营养配方食品对肝病有显著的治疗作用。
以上所述仅为本发明的优选实施例而已,并不用于限制本发明,对于本领域的技术人员来说,本发明可以有各种更改和变化。凡在本发明的精神和原则之内,所作的任何修改、等同替换、改进等,均应包含在本发明的保护范围之内。
Claims (4)
1.一种适用于肝病患者的全营养配方食品,其特征在于,包括以下成分:石斛、山楂、灵芝、制黄精、木瓜、蜂胶、蒲公英、马齿苋、枳椇子、蛹虫草、决明子、黑芝麻、黑豆、谷芽、薄荷、芡实、莲子、麦芽、栀子、杭白菊、厚朴花、佛手、绿梅花、乌梅、玳玳花、佛手花、薏苡仁、扁豆、线叶金雀花、杜仲雄花、青钱柳叶、显齿蛇葡萄叶、裸藻、丹凤牡丹花、辣木叶、富硒植物蛋白粉、低聚甘露糖。
2.如权利要求1所述的适用于肝病患者的全营养配方食品,其特征在于,包括以下重量百分比的成分:石斛0.5-1%、山楂0.2-0.5%、灵芝1-2%、制黄精0.1-0.2%、木瓜0.2-0.5%、蜂胶0.1-0.3%、蒲公英0.5-1%、马齿苋1-2%、枳椇子2-3%、蛹虫草0.5-0.8%、决明子1-2%、黑芝麻8-15%、黑豆10-20%、谷芽2-3%、薄荷1-2%、芡实0.5-1%、莲子1-2%、麦芽0.5-1%、栀子1-2%、杭白菊1-2%、厚朴花2-3%、佛手0.5-1%、绿梅花1-2%、乌梅0.5-1%、玳玳花0.5-0.8%、佛手花0.2-0.5%、薏苡仁1-2%、扁豆1-2%、线叶金雀花1-2%、杜仲雄花1-1.5%、青钱柳叶0.2-0.5%、显齿蛇葡萄叶0.3-0.8%、裸藻0.2-0.4%、丹凤牡丹花0.1-0.3%、辣木叶2-3%、富硒植物蛋白粉30-50%和低聚甘露糖 余量。
3.如权利要求1所述的适用于肝病患者的全营养配方食品,其特征在于,包括以下重量百分比的成分:石斛0.8%、山楂0.3%、灵芝1.5%、制黄精0.15%、木瓜0.35%、蜂胶0.2%、蒲公英0.7%、马齿苋1.2%、枳椇子2.5%、蛹虫草0.7%、决明子1.5%、黑芝麻12%、黑豆16%、谷芽2.8%、薄荷1.5%、芡实0.7%、莲子1.5%、麦芽0.8%、栀子1.4%、杭白菊1.6%、厚朴花2.2%、佛手0.8%、绿梅花1.5%、乌梅0.8%、玳玳花0.6%、佛手花0.4%、薏苡仁1.3%、扁豆1.5%、线叶金雀花1.6%、杜仲雄花1.3%、青钱柳叶0.4%、显齿蛇葡萄叶0.5%、裸藻0.3%、丹凤牡丹花0.2%、辣木叶2.4%、富硒植物蛋白粉35%和低聚甘露糖 余量。
4.如权利要求1所述的适用于肝病患者的全营养配方食品,其特征在于,所述的富硒植物蛋白粉的硒含量是35-60mg/kg。
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710034125.XA CN107156829A (zh) | 2017-01-18 | 2017-01-18 | 一种适用于肝病患者的全营养配方食品 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710034125.XA CN107156829A (zh) | 2017-01-18 | 2017-01-18 | 一种适用于肝病患者的全营养配方食品 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107156829A true CN107156829A (zh) | 2017-09-15 |
Family
ID=59849328
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710034125.XA Pending CN107156829A (zh) | 2017-01-18 | 2017-01-18 | 一种适用于肝病患者的全营养配方食品 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN107156829A (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108552529A (zh) * | 2018-04-29 | 2018-09-21 | 广东伊茗药业有限公司 | 一种适用于肝病患者的全营养配方食品 |
CN109349641A (zh) * | 2018-12-21 | 2019-02-19 | 广东冠龙生物科技有限公司 | 一种藏红花素和藤茶复合含片及其制备方法 |
CN112970909A (zh) * | 2021-04-07 | 2021-06-18 | 山西农业大学 | 青仁黑豆皮有效成分提取方法、组合物、药茶制备方法及应用 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104839656A (zh) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | 肝病医学配方食品 |
CN105724875A (zh) * | 2014-12-08 | 2016-07-06 | 恩施盛硒生物工程有限公司 | 一种保护肝脏功能的富硒果蔬精华片 |
-
2017
- 2017-01-18 CN CN201710034125.XA patent/CN107156829A/zh active Pending
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN105724875A (zh) * | 2014-12-08 | 2016-07-06 | 恩施盛硒生物工程有限公司 | 一种保护肝脏功能的富硒果蔬精华片 |
CN104839656A (zh) * | 2015-04-10 | 2015-08-19 | 劲膳美生物科技股份有限公司 | 肝病医学配方食品 |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN108552529A (zh) * | 2018-04-29 | 2018-09-21 | 广东伊茗药业有限公司 | 一种适用于肝病患者的全营养配方食品 |
CN109349641A (zh) * | 2018-12-21 | 2019-02-19 | 广东冠龙生物科技有限公司 | 一种藏红花素和藤茶复合含片及其制备方法 |
CN112970909A (zh) * | 2021-04-07 | 2021-06-18 | 山西农业大学 | 青仁黑豆皮有效成分提取方法、组合物、药茶制备方法及应用 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Kumar et al. | Recent trends in potential traditional Indian herbs Emblica officinalis and its medicinal importance | |
JP6077554B2 (ja) | 薬用花を活用した包み発酵法およびこれを活用した皮膚外用剤組成物 | |
KR101805004B1 (ko) | 약용 잎을 활용한 쌈 발효법 및 이를 활용한 피부 외용제 조성물 | |
KR101090284B1 (ko) | 홍삼과 녹용 추출물을 포함하는 드링크제 및 그의 제조방법 | |
KR20110129673A (ko) | 숙취 해소용 한약 조성물 및 이를 함유하는 음료 | |
CN107156828A (zh) | 一种适用于炎性肠病患者的全营养配方食品 | |
KR20160087112A (ko) | 꽃차 및 이의 제조방법 | |
CN103416534A (zh) | 一种富硒养胃茶及其生产方法 | |
KR20150040392A (ko) | 스테비아 음료원액제조방법 | |
CN105454576A (zh) | 茉莉花八宝茶及其制备方法 | |
CN105010669A (zh) | 一种清润保健茉莉花茶及其生产方法 | |
KR20090032158A (ko) | 가압전이(加壓轉移)에 의한 과일 침출 및 액상 차 조성물과 그 제조방법 | |
Reid | A Handbook of Chinese Healing Herbs: An Easy-to-Use Guide to 108 Chinese Medicinal Herbs and Dozens of Prepared Herba l Formulas | |
CN107156829A (zh) | 一种适用于肝病患者的全营养配方食品 | |
KR20120131337A (ko) | 인진쑥, 헛개나무, 민들레, 대추, 갈근 및 오가피의 각각의 추출물을 주성분으로 함유하는 기능성 음료 조성물 | |
CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
CN104522661A (zh) | 含金银花提取物的保健含片及其生产方法 | |
CN106880042A (zh) | 一种适用于肥胖、减脂手术患者恢复期的全营养配方食品 | |
KR20180089696A (ko) | 천연식물 추출물의 잔류농약 제거방법 | |
CN106701410A (zh) | 健胃益气保健酒及其生产方法 | |
KR101999675B1 (ko) | 관상동맥성 심장질환의 예방과 치료용 생약조성물 | |
KR20160147424A (ko) | 와송 추출물이 포함된 효소조성물 | |
Chillemi | The complete guide to natural healing: a natural approach to healing the body and maintaining optimal health using herbal supplements, vitamins, minerals, fruits, vegetables and alternative medicine | |
CN107712890A (zh) | 一种宁心安神膏滋及其制备方法 | |
CN103301342A (zh) | 一种促进生发中药制剂的配方及制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170915 |
|
RJ01 | Rejection of invention patent application after publication |